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Background: Nutritional factors as modifiable risk factors for physical function 
have not been adequately investigated, and published findings are inconsistent 
and/or insufficient. Little data is available for Asian populations.  
 
Objective: To investigate aspects of the relationship between selected 
nutritional factors (albumin, hemoglobin, homocysteine, folate, and vitamin B-
12), tea consumption, with physical functional status and performance in older 
adults aged 55 and above.  
 
Methods: The Singapore Longitudinal Ageing Study (SLAS) is a prospective 
cohort observational study of ageing and health among community-dwelling 
elderly Singaporeans. During recruitment and baseline data collection between 
September 2003 and December 2005, all older adult residents aged ≥55 years 
(N=2,804, 78% response rate) were identified by door-to-door census in South 
East Singapore for participation in the study and follow up assessment 1-2 years 
(median=1.5 years) later.  
 
Physical performance was measured by performance oriented mobility 
assessment at baseline. Physical function was measured by Basic Activity of 
daily living and Instrumental Activity of Daily Living both at baseline and 
follow-up. Serum albumin, hemoglobin, serum folate, serum vitamin B-12, 
plasma total homocysteine, and tea consumption were measured at baseline. 
x 
 
Data collected on confounding variables included cigarette smoking, alcohol 
consumption, cardiometabloic risk factors, cognitive function and depression. 
Study I investigated the relationships between albumin, hemoglobin and 
physical function and IADL performance, and functional decline. Study II 
examined the independent effect of serum folate, serum vitamin B12 and plasma 
homocysteine on physical function and IADL performances. Study III 
investigated the effects of tea consumption on physical function and 
performances. 
 
Results: Study I found that albumin showed a significant association (p<0.01) 
with POMA balance score (b=0.05, SE=0.02) and knee extension strength 
(b=0.70, SE=0.10). Independently of albumin, hemoglobin also showed a 
significant linear association with POMA balance score (b=0.09, SE=0.04). In 
longitudinal analyses, albumin was significantly associated with IADL decline 
(IADL total score drop>=1 during follow-up), OR= 0.92 (0.87 - 0.97), p=<0.01. 
In Study II, homocysteine, independently of folate and vitamin B12, showed 
significant negative associations with POMA balance (p=0.04), POMA gait 
scores (p<0.01) and IADL (p<0.01). Serum folate showed significant positive 
association only with POMA balance scores (p<0.038). No significant 
independent associations for B12 were observed. Study III showed that 
black/oolong tea high consumption was positively associated with better POMA 
balance score (B=0.78, SE=0.35 p trend 0.01), marginally associated with 
POMA gait score (B=0.07, SE=0.07 p trend =0.07) and IADL (B=0.26, SE=0.19 
xi 
 
p trend=0.07). Green tea high consumption was positively associated with 
POMA balance (B=0.72, SE=0.23 p trend 0.02), POMA gait score (B=0.09, 
SE=0.05 p trend =0.03) and IADL (B=0.29, SE=0.13 p=0.04).Coffee 
consumption was not significantly associated with physical function. 
 
Conclusions: Poor nutritional status was associated with poor physical 
performance. Low levels of albumin and hemoglobin are potentially useful risk 
markers of physical functional decline in older adults. The independent 
association of elevated homocysteine and low folate, but not B12, on physical 
and functional decline was supported in this study. Tea consumption was 
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CHAPTER 1 INTRODUCTION 
In ageing societies, the health services and social care needs of physically 
disabled older persons are a cause of great societal concern and burden. It is 
extremely important to find modifiable risk and protective factors for physical 
limitation and functional disability. Previous studies examined the association of 
the risk factors with physical limitation and functional disability and these 
factors are heavy consumption of alcohol [1] , smoking [2], cognitive 
impairment, depression [3], disease burden (comorbidity) [4], increased and 
decreased body mass index [5], lower extremity functional limitation [6], low 
level of physical activity [7], and vision impairment [8]. Physical activity, social 
interaction, maintaining normal weight, and being proactive in preventive health 
care may have a protective effect on physical limitations and functional 
disability [9, 10]. Decreasing disability into the future will assure not just a 
longer lifespan, but a better quality of life. 
 
This thesis focused on aspects of the relationship between physical performance, 
functional disability and nutritional markers (albumin, haemoglobin, folate, 
vitamin B12), homocysteine and tea consumption in the community-living older 
adults, Chapter 1 presented the general background and context of the current 
study. 
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1.1 Rapidly Ageing population and its impact 
 In most developed countries, birth rate is declining and the proportion of the 
elderly population is high and growing steadily. The proportion of Singapore 
residents aged 65 years and above increased to 9% in 2010 as compared to 7.2% 
a decade ago [11].According to 2008 International population reports, the older 
population of Singapore is expected to be triple by 2040 [12]. 
 
Singapore’s rapidly ageing population combined with the growing, silent 
epidemic of chronic diseases like Type II Diabetes Mellitus, cardiovascular 
diseases and cancers, poses a complex set of challenges which affect not only 
our physical but also our economic health. It is necessary for the elderly 
population to have a good quality of life even though they may have physical 
illness or live in poor social conditions. 
 
1.2 Physical performance, functional disability and physical decline in the 
older population 
In aging societies, physical disability is clearly a major public health problem 
[13]. In older adults, diseases and other medical conditions may accelerate the 
disablement process via biochemical and biological mechanisms, which then 
leads to impairments, followed by functional limitations and disabilities [14].  
 
Increased risks of functional status decline and late life disability are influenced 
by various factors, such as cognitive impairment, co-morbidities, depression, 
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increased body mass index, weight loss, lower extremity functional limitation, 
low frequency of social contact, low physical activity score, alcohol use and 
smoking. Many of these factors are modifiable and are linked to socio-
demographic characteristics [15]. The main causes of physical disability in later 
life are chronic diseases [16, 17]. A number of co-morbidities including 
cardiovascular disease, neurologic disease, hypertension, diabetes mellitus and 
some types of cancer may be amenable to nutritional intervention [18]. 
However, nutritional risk factors have not been well studied in past research. 
 
1.3 Nutrition as potential modifiable risk factor and protective factor 
 In ageing societies, the reduction of the societal burden of functional disability is 
a priority for targeted intervention. To devise and implement effective strategies 
for preventing or delaying the onset of physical disability, it is important to 
identify modifiable risk factors of physical functional limitations and disability. 
However, the contribution of nutritional risk factors to physical performance and 
functional disability in the elderly is not well studied.  
 
The evaluation of nutritional status is a primary component of various geriatric 
assessments [19, 20]. Studies have shown that nutritional factors could predict 
physical functional decline and delay the onset of physical disability. A previous 
study found that 30% to 50% of nursing home elderly had substandard body 
weight and mid-arm circumference and low albumin concentrations [21].There 
is a relationship between involuntary weight loss with morbidity and mortality 
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[22, 23], and prior studies found an association between malnutrition and 
dysfunction and disability [23, 24]. Disability in activities of daily living (ADLs) 
is the consequence of chronic diseases and age-related physiological changes. 
ADLs disability was an important risk factor for institutionalization, recurrent 
hospitalization, and other poor health outcomes in the elderly [25]. 
 
McLaren D.S. et. al [26] found that albumin levels are associated with long-term 
protein-energy deprivation, and Salive M. et.al [27] demonstrated that a 
relationship between serum albumin and poor physical function exists. The 
consequence of nutritional deficiencies may therefore be a decline in functional 
status [28]. 
 
Since nutritional status is modifiable through dietary or supplement intervention, 
the public health impact is huge when the association between a nutritional 
factor (s) and physical function is firmly established. Large population-based 
studies on this topic are necessary although the final conclusion may have to 
come from well-designed randomized controlled trials directed by the results of 
observational population studies. 
 
1.4 Objectives of the current study 
The data drawn from a community based study sample of elderly (aged 55 and 
above) form Singapore Longitudinal Ageing Studies (SLAS). The thesis focuses 
on aspects of the relationship between physical function and selected nutritional 
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factors: albumin, haemoglobin, homocysteine, folate, vitamin B12 and 
consumption of tea as a healthy dietary habit. Among these factors, albumin and 
haemoglobin are conventional markers of nutritional status while folate and 
vitamin B12 are associated with homocysteine in one-carbon metabolism and tea 
catechin as a phytochemical. The underlying biological activity of tea 
consumption and its contributions to human health is an area of research interest. 
No study has yet investigated this association with respect to consumption of 
black tea and performance-based measures of physical function in the elderly. 
For ease of reference, each study is referred as Study I, Study II and Study III 
respectively throughout the thesis. 
 
The objectives are: 
Study I: To examine the independent association between serum albumin, 
haemoglobin and physical function and performances (assessed by self-reported 
IADL and performance based tests, POMA Balance, Gait, Knee Extension 
Strength) in community-living older persons.  
 
Study II: To examine the relationships between folate, vitamin B12, 
homocysteine and physical function and performances (assessed by self-reported 
IADL and performance base tests, POMA Balance, Gait) in community-living 
older adults.  
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Study III: To examine the relationships between tea consumption and physical 
function and performances (assessed by self-reported BADL, IADL and 
performance base tests, POMA Balance, Gait, Knee Extension Strength) in 
community-dwelling elderly.  
 
1.5 Hypotheses 
Study I.  
Presence of a linear association between serum albumin and haemoglobin with 
measures of physical function, and albumin or haemoglobin is exerted a more 
pronounced effect on physical function in relation to each other 
 
Study II 
There are the relationships between folate, vitamin B12, homocysteine and 
physical function and performances (assessed by self-reported IADL and 
performance base tests, POMA Balance, Gait) in community-living older adults.  
 
Study III:  
Existence of the relationship between tea consumption and physical function and 
performances (assessed by self-reported BADL, IADL and performance base 
tests, POMA Balance, Gait, Knee Extension Strength) in community-dwelling 
elderly. 
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These studies would contribute to the understanding of the roles of nutritional 
factors on physical function and performances in the elderly. It could provide the 
evidence and justification for future clinical trial designs and the establishment 
of a prevention and intervention framework for physical functional limitation 
and physical decline. 
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CHAPTER 2 LITERATURE REVIEW 
The literature review focuses on experimental, epidemiological and clinical 
studies that are related to this thesis.  
 
2.1 Nutritional status and physical function in the elderly 
Proper nutrition plays a role in physical function and performances especially in 
older adults. In the past, both dietary intake and conventional clinical markers of 
nutritional status have been engaged as nutritional status indicators and the 
association between nutrition and physical function and performances in the 
older adults has been examined. 
 
Physical function is generally recognized as an essential component of quality of 
life and is perhaps the most universally accepted aspect of the definition of 
health [29]. Physical function decline can be the result of poor nutritional status. 
Poor nutritional status may accelerate age-associated loss of skeletal muscle 
mass, termed sarcopenia. It is known that the human ageing process is associated 
with a significant decline in neuromuscular function and performance. 
Sarcopenia is used to describe age-related changes that occur within skeletal 
muscle and there are a number of contributing factors such as the alteration of 
central and peripheral nervous system innervation, hormonal status, and 
inflammatory effects. In older adults, sarcopenia, skeletal muscle atrophy and 
weakness are considered major contributing factors to physical functional status 
decline and disability [30]. 
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Sarcopenia has been defined as the loss of skeletal muscle mass and strength that 
occurs with advancing age [31]. Previous studies proposed definitions of 
sarcopenia in older people [32, 33] However, a widely accepted definition of 
sarcopenia suitable for use in research and clinical practice is still lacking.  
 
Experts from different medical fields suggested diagnosing sarcopenia when the 
following criteria are fulfilled; a low muscle mass and a low gait speed [34]. The 
European Working Group on Sarcopenia in Older People suggested that 
sarcopenia diagnosis is based on documentation of Low muscle mass plus (Low 
muscle strength or Low physical performance) [35]. There are currently 
numerous parameters and markers, such as physical performance measures, 
muscle strength measures, anthropometry, dual energy X- ray absorptiometry, 
computerized tomography, magnetic resonance imaging, inflammation, 
oxidative damage, and nutritional parameters (albumin and haemoglobin, etc) 
that are potentially able to track sarcopenia [36]. There are some evidences 
shown that serum albumin or haemoglobin levels are related to sarcopenia. 
Baumgartner R.N. et.al suggested that lower serum albumin concentration is 
associated with sarcopenia [37]. Penninx, B.W., et al., examined that lower 
hemoglobin is associated with lower muscle strength and physical performance 
in elderly [38]. Pro-inflammatory cytokines such as Interleukin-6 and Tumor 
Necrosis Factor alpha are associated with muscle mass and muscle strength [39].  
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While research over decades have established a large number of modifiable risk 
factors for functional status decline in the elderly, nutritional factors have not 
been adequately investigated thus far [15].  
 
2.1.1 Dietary intake and physical function 
A healthy and balanced diet provides fuel for biological process and chemicals 
for extracting and using the potential energy within this fuel. Micronutrients and 
macronutrients from food also deliver essential elements to regulate 
physiological and biochemical mechanisms in the body and enhance physical 
function and performance. Malnutrition is a serious problem experienced by the 
elderly. In the InCHIANTI study, Bartali et al [40] assumed that poor nutrient 
intake is a part of frailty. They provided evidence that a low intake of nutrition 
was associated with poor muscle strength in frail elderly.  
 
Dietary intake itself may not be an accurate indicator of nutritional status of 
older adults because many other important factors (e.g. defective dentition, 
gastrointestinal maldigestion and malabsorption, polypharmacy, food-drug 
interaction) have not been taken into account. For this reason, biochemical or 
anthropometric markers have been utilized to represent nutritional status in other 
epidemiology and experimental studies. In view of this, literatures on albumin 
and haemoglobin are reviewed in the following sections. 
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2.1.2 Albumin and physical function 
Albumin is a soluble and monomeric protein (M, 69,000) that is present in 
human plasma at high concentration around 40 g/L and has a rapid turnover rate. 
It is an endogenous protein produced in the liver and reflects both nutritional 
sufficiency as well as underlying health condition especially that related to the 
function of liver, kidney and also to the stress response. Among the functions of 
serum albumin is its role in maintaining the osmotic pressure and transport of 
many substances, including hormones, fatty acids and drugs, which are well 
known.  
 
Prior studies investigated how serum albumin plays important roles in 
fibrinolysis, hemostasis and platelet aggregation [41], infection and 
inflammation [42], and oxidative damage [43]. Albumin has been proposed to be 
a marker of inflammatory response and increased vascular permeability, which 
underlines various chronic diseases [44]. 
 
Epidemiologic studies have investigated how low serum albumin was negatively 
associated with the risk of coronary heart disease, stroke, diabetes mellitus and 
other cardiovascular risk factors [44,28, 29, 30, 34-36]. However, few studies 
have investigated the relationship between albumin and physical function and 
performances. 
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Albumin is a marker of nutritional status [51,-53]. The National Integrated 
Project for Prospective Observation of Non-communicable Disease and Its 
Trends in the Aged (NIPPON DATA) study studied the association between 
serum albumin and total cholesterol (TC) and the activities of daily living 
(ADLs) in elderly people. Among 1844 Japanese individuals aged 60 to 74 
(randomly selected throughout Japan and followed for 12.4 years), it was 
revealed that lower serum albumin was associated with impaired performance in 
the activities of daily living (ADL) [54]. Among the community-living older 
adults, they found that the association between serum albumin and impaired 
ADLs was stratified according to the median of serum total cholesterol level 
(OR for 1-g/L increase in serum albumin = 0.88 for men (95% CI = 0.79 – 0.97) 
and 0.79 for women (95% CI = 0.72 – 0.87) in the group below the median of 
total cholesterol after adjustment for some variables. Although they examined 
the relationship between albumin and self-reported ADL, they did not assess the 
instrumental activities of daily living (IADL), which includes cognitive domains 
such as managing money, taking medications, using telephone. In our study we 
assessed IADL as one of the dependent variable and analysed with adjusting 
variables including MMSE. Therefore, the association between albumin and 
IADL may not be influenced by cognitive function. 
 
A population-based cohort study (The Longitudinal Ageing Study Amsterdam) 
suggested that low serum albumin was associated with a decline in muscle 
strength. Among 1320 participants aged 65 to 88, it was reported that lower 
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serum albumin was associated with muscle strength decline over 3 years (P < 
0.01) in women (β = 0.57, standard error (SE) = 0.18) and men (β = 0.37, SE = 
0.16) [55]. 
 
A previous cohort study, the MacArthur Research Network on Successful 
Ageing Community Study, assessed functional status using the Rosow-Breslau 
functional status scale and examined the relationship between measures of 
inflammation and the risk of functional decline [56]. In another population-based 
longitudinal study, Schalk B.W.M. et al investigate the association of serum 
albumin and functional decline using performance-based tests [57]. However, 
these studies have also reported that albumin alone did not independently predict 
physical function decline measured by subjective questionnaire [56] or objective 
performance tests [57]. The inconsistent results could possibly be attributed to 
the use of different instruments with varying sensitivity to assess physical 
functional performance. 
 
2.1.3 Haemoglobin and physical function 
Another biomarker of nutritional status is haemoglobin [58, 59] A growing body 
of evidence has linked "mild" anemia or low-normal haemoglobin in the elderly 
to adverse events [40]. In the women’s health and ageing study I and II, Chaves 
P.H.M et.al evaluated the relationship between haemoglobin and physical 
performance and prevalent mobility difficulty [41]. Denny S.D. et.al explored 
the impact of haemoglobin levels on physical function. The prospective cohort 
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study included 1744 participants, aged 71 years and above. They investigated 
the association between anemia and increase risk of functional decline [42]. A 
community based cross sectional study in Italy examined the relationship 
between low haemoglobin and physical performance, muscle strength, and 
disability in older adults. In that study, 1,156 participants aged 65 and above 
were included and they found that low haemoglobin was independently 
associated with poor physical performance, lower muscle strength, and more 
disability in both BADL and IADL[43].  
 
Penninx B.W.J.H et.al examined whether low haemoglobin increases the risk of 
physical function decline. The prospective cohort study included 1146 
participants aged 71 years and above and they measured physical function using 
performance based tests. They reported the association between low 
haemoglobin and physical performance decline over 4 years and the association 
was also present in participants who were free of anemia associated diseases 
such as cancer, infectious disease[64].  
 
2.1.4 Albumin, Haemoglobin and physical function 
In previous studies, the relationship between albumin and haemoglobin with 
physical function has been studied in isolation, and not in tandem. Hence, their 
independent and relative effects on physical function are unclear. Albumin and 
haemoglobin are associated with distinct physiological processes and biological 
mechanisms in human body. Low albumin concentration is associated with 
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sarcopenia [65] and muscle strength decline [55] in the elderly. Albumin has 
been proposed to be a marker of inflammatory response and increased vascular 
permeability, which underlies various chronic diseases [44]. Low haemoglobin 
is well known to occur in individuals with chronic disease as a result of 
suppressed erythropoiesis by systemic inflammation [66].  
 
Serum albumin is associated with sarcopenia in older persons [65]. Muscle 
depletion lead to decline in muscle strength, which could mediate the observed 
albumin-physical function associations. Albumin is a negative acute phase 
protein that decreases with systemic inflammation. Furthermore, the association 
between albumin and physical function is also partly explained by chronic 
inflammation since pro-inflammatory cytokines may cause muscle atrophy and 
has been associated with physical disability [67] or function decline [56]. The 
relationship between haemoglobin and physical function may be secondary to 
the effects of fatigue, weakness, poor muscle oxygenation, and low level of 
physical activity that was associated with anemia [63, 68, 69].  
 
In the present study, we measured albumin and haemoglobin together and 
physical function using both performance-based tests and self-reported 
questionnaires in a large sample of the community. We tested the hypothesis of 
linear associations between serum albumin and haemoglobin with measures of 
physical function, and investigated whether albumin or haemoglobin exerted a 
more pronounced effect on physical function in relation to each other.  
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2.2 Homocysteine, folate, vitamin B12 and physical function 
Micronutrient deficiencies are common among older adults. The ability of 
gastric acid production decreases in the elderly. Atrophic gastritis is the most 
common cause of decreasing gastric acid decreasing. The decrease of gastric 
acid production may affect the absorption of both cobalamin and folate [68]. 
Ageing-related disturbances in absorption, transport and metabolism are 
contributing factors for folate and B12 (cobalamin) deficiencies, as well as 
hyperhomocysteinaemia [71, 72].  
 
Folate, also known as folic acid or folacin, are water-soluble vitamins in the 
vitamin B group and are found in nearly all natural foods of both plant and 
animal origin. Folate plays a role in reducing blood homosysteine levels, 
formation of red blood cells, protein metabolism and cell growth and division. 
The normal range of folate stored in the body is about 10-20 mg in a well-
nourished adult. A randomized control trial examined that folate, vitamin B6 and 
vitamin B12 reduce plasma homocysteine level and may reduce the number of 
vascular events among patients who undergone percutaneous coronary 
intervention [73]. Insufficient dietary intake of folate is a common cause of 
folate deficiency [74]. Folate deficiency can cause hematological consequences 
e.g. megaloblastic anemia [75], neurological consequences e.g. cerebral 
dysfunction, progressive dementia, bilateral pyramidal tract sign [76], and 
metabolic consequences e.g. substandard suppression by deoxyuradine [77]. 
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Vitamin B12 functions as a coenzyme for critical methyl transfer reactions and it 
is also required for normal blood formation and neurologic functions [78]. The 
recommended dietary allowance for vitamin B12 is based on the amount needed 
for the maintenance of hematological status and normal serum vitamin B12 
values. They are absorbed into the blood by the small intestine via an active 
process that requires an intrinsic factor [79]. In 10 to 30 % of ≥ 50 years older 
adults, lowering of stomach acid secretion was caused by atrophic gastritis and 
seriously impaired Vitamin B12 absorption [80, 81]. 
 
Homocysteine (Hcy) is a sulfhydryl amino acid that is methylated via 
methionine-synthase to form methionine by a reaction requiring folate and 
vitamin B12. Elevated homocysteine is recognized as a sensitive marker for 
folate and vitamin B 12 deficiency, [72, 82], as high plasma levels of total 
homocysteine (tHcy) are associated with low levels of folate and B12. 
Homocysteine is also elevated in association with vitamin B6, alcohol and 
caffeine intakes, smoking, hypertension and impaired renal and thyroid function 
[83]. Plasma tHcy concentrations are also associated with cardiovascular 
diseases, cerebrovascular diseases, stroke, psychiatric disorders, and cognitive 
impairment in the elderly [77, 84, 85].  
 
Homocysteine may contribute to the vascular diseases by plausible mechanisms 
such as endothelial dysfunction and damage, thrombin formation, lipid 
peroxidation through free radical formation, and inducing vascular smooth 
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muscle proliferation [86, 87]. There are plausible biological mechanisms that 
may explain the relationship between tHcy levels and cognitive function. 
Firstly, elevated tHcy is an independent risk factor for cerebrovascular disease, 
[88] which in turn is a risk factor for cognitive decline and dementia.[89]. 
Secondly, high tHcy levels may be a marker of impaired methylation reactions 
in brain tissue, which play an important role in the production of 
neurotransmitters, phospholipids, and myelin [90]. Thirdly, high tHcy may 
promote β amyloid-peptide mediated toxic effects on neuronal cells.[91]  
 
The mechanism underlying the relationship between homocysteine and 
depression may be explained by which high homocysteine is a risk factor for 
stroke and small vessel disease [92,93], and may, thereby, increase the risk of 
vascular depression.  
 
McDermott, M.M., et al suggested that elevated homocysteine is associated 
with lower calf muscle mass in persons with peripheral arterial disease [105]. 
The underlying mechanism of the association between homocysteine and 
sarcopenia may be explained by the homocysteine-induced inflammatory 
responses. Homocysteine might play an important role in the progression of 
vascular inflammation [94].Inflammatory cytokines such as tumour necrosis 
factor alpha induce muscle proteolysis and loss of skeletal muscle mass [95] 
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Prior studies have shown that elevated homocysteine concentration is associated 
with increased risks of stroke and cardiovascular disease [96], cognitive decline 
and dementia [97] and osteoporotic fractures [98-100], these conditions are 
major medical conditions contributing to functional impairment and disability in 
the elderly. The underlying mechanism of the association between the level of 
homocysteine and the risk of fracture may involve interference by homocysteine 
in collagen cross-linking [99]. 
 
However, randomized control trials shown that folic acid supplementation did 
not significantly contribute to cardiovascular disease, stroke, or myocardial 
infarction. These results have led to doubts about the causality of the effect of 
plasma homocysteine on cardiovascular disease and cerebrovascular diseases 
[101]. 
 
In a prospective cohort study that involved 499 highly functional men and 
women aged 70 to 79 years, Kado D.M. et al. found that for each SD increase in 
homocysteine, there was an increased risk of physical function decline (odds 
ratio=1.5; 95% confidence interval: 1.2 to 1.9). The above study suggested that 
higher plasma homocysteine levels concern an increased risk of cardiovascular 
disease and also affect the risk of functional decline [102]. A later cross 
sectional study confirmed the association between elevated homocysteine and 
motor performance. In the Three-City study [103], noninstitutionalized 
individuals aged 65 or above were selected. It was found that the odds ratio 
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(OR) for having a maximum walking speed below the 40th percentile was 1.9 
[(95% CI) 1.4 to 2.5] in subjects with tHcy levels in the upper quintile, 
compared with those in the lowest quintile.  
 
In the Malmö OPRA study, they investigate the association between Hcy levels 
and physical performance [104]. In that study, 996 old women participants were 
included and they found that gait speed was 11% slower among women with 
Hcy in the highest quartile compared with the other women (p < 0.05). 
 
Kup H.K. et al. explored the association between elevated homocysteine and 
muscle strength and physical performance [105]. Participants (>60 years, N = 
1677) were from the National Health and Nutrition Examination Survey 
(NHANES) and they investigated that the odds ratios (ORs) for disability in 
ADL was 2.18 (95% CI, 1.32–3.59) and for IADL disability was 1.62 (95% CI, 
1.02–2.57), comparing participants in the highest quartile of homocysteine to 
those in the lowest quartile.  
 
Furthermore, other studies explored elevated homocysteine and found it to be 
independently associated with strength, gait and balance and velocity measures 
of worse lower limb physical performance [106-109] or risk of osteoporosis or 
falls [110-115]. 
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However, with few exceptions, these studies did not include folate and vitamin 
B12, which are the major nutritional determinants of homocysteinemia and 
potential independent risk factors for physical decline. Given the paucity of 
studies that examined these metabolites together and the inconsistent findings, 
the independent effects of homocysteine, folate and B12 on physical 
performance and functional disability therefore require further investigation. 
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2.3 Tea consumption  
Tea is one of the most widely consumed beverages in the world [116]. Leaves 
and buds of the plant Camellia sinensis are used to produce 3 main types of tea: 
black tea (fully fermented), oolong tea (semi-fermented), and green tea (non-
fermented). Of the total tea production worldwide, black tea accounts for 78%, 
followed by green tea and oolong tea respectively [117]. The antioxidant and 
health effects of tea are well documented and attributed to its major components, 
catechins (namely epicatechin, epicatechin-3-gallate, epigallocatechin and 
epigallocatechin-3-gallate, also known as EGCG), and theaflavins and 
thearubigins which are formed by the oxidation and polymerization of catechins 
during black tea processing. Besides tea catechins, tea leaf contains theanine, 
caffeine and other alkaloids, amino acids, carotenoid and other pigments, 
carbohydrates, organic acids, minerals, vitamins, enzymes, and many other 
ingredients [118]. 
 
Previous studies on the absorption and transport of tea flavonols in people show 
that the time needed to reach the highest plasma concentration of flavonols was 
in the range of 1.5-2.4 hrs after tea consumption [119-121]. There is some 
controversy that the addition of milk to tea can cause disturbance of the 
absorption of tea flavonoids because of the milk proteins binding with 
flavonoids[122], however, P.C. Hollman et.al found that flavonols are absorbed 
from tea and that their bioavailability is not affected by addition of milk 
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[123]The maximum amount of flavonols is excreted in the urine within 9hr after 
tea ingestion [119].  
 
Hegarty V.M. et al [124] examined the relationship between tea consumption 
and bone mineral density (BMD) in older women in Britain. Low bone mineral 
density is a significant risk factor for fractures in older women. In Britain, tea 
consumption with milk is common. Because of the milk consumption which is a 
valuable source of calcium, milk might be a confounder in the relation between 
tea drinking and bone mineral density (BMD). Even though an effect of milk 
consumption on BMD cannot be excluded, older women who drank tea with no 
milk have higher BMD measurement than in women who did not drink tea is 
consistent with an effect of tea independent of the addition of milk to tea. 
 
2.3.1 Tea consumption and chronic diseases 
Prior studies investigated and found tea polyphenols to possess an antioxidant 
activity, which protects cells against the adverse effects of reactive oxygen 
species (ROS). ROS, such as superoxide radical, hydroxyl radical, singlet 
oxygen, and hydrogen peroxide cause damage to proteins, lipids, and cellular 
components, consequently causing cellular injury and dysfunction [125]. 
 
In elderly, oxidative protein damage relates to lower muscle strength and 
consequently it also implicates pathogenesis of sarcopenia. It may play a major 
role in the decline of functional activity [126-128]. Moreover, free radical 
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oxidative stress implicates the pathogenesis of a variety of diseases, and in those 
diseases, natural antioxidant defenses are found to be defective. Antioxidant 
therapy may be beneficial for the diseases like diabetes mellitus, reperfusion 
injury and inflammatory diseases [129]. Furthermore, many other accumulations 
of reactive oxygen species throughout the human lifespan are known to 
contribute to ageing [130]. Plasma antioxidants improve physical performance 
and muscle strength [131].  
 
The components of tea (catechin, theaflavins, thearubigins) possess antioxidative 
properties [132-134]. The consumption of antioxidant-rich foods decreases 
levels of oxidative damage in vivo in humans [135, 136]. Serafini et al. [137] 
reported that consumption of green tea and black tea increases total antioxidant 
content in human blood plasma. However, a review study mentioned that 
polyphenols have a limited bioavailability and only low concentrations are 
present in the systemic circulation and tissue compared with other antioxidants. 
Additionally, polyphenol metabolism during absorption diminishes their 
antioxidant activity and suggested that polyphenols may not prevent oxidative 
damage by direct antioxidant actions [138]. 
 
Epidemiologic studies found protective effects of polyphenol to coronary artery 
disease [139].Lamy S. et.al reported that green tea catechins are novel inhibitors 
of VEGFR-2, Vascular endothelial growth factor (VEGF) receptors which play a 
major role in tumor angiogenesis[140]. Holst B et. al examined the role of 
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phytochemicals, which are processed by the body as xenobiotics, activating the 
Nrf2/Keap 1 pathway that result in increased expression of genes encoding 
cytoprotective proteins [141].Previous studies have suggested that the 
Nrf2Keap1 system contributes to protection against various pathologies, 
including carcinogenesis, liver toxicity, respiratory distress and 
inflammation[142-144]. 
 
Tea constitutes anti-inflammatory properties, which could contribute to its 
neuroprotective effects [147, 148] and also to the prevention of functional 
limitation and disability. Moreover, in animal studies, it is proven that tea has 
positive benefits on collagen-induced arthritis and green tea polyphenol-fed 
mice have less inflammation [149]. One of the underlying biological 
mechanisms which reduce physical function is chronic inflammation [150, 151].  
 
2.3.2 Tea consumption and physical function 
In an ageing population, the burden of disability becomes an important societal 
concern. The main causes of physical disability in later life are chronic diseases 
[16, 17]. Previous study supported the hypothesis that tea components especially 
flovonols and flavonones protect against several chronic diseases such as 
cardiovascular disease, cerebrovascular disease and cancer [152]and thereby, tea 
consumption may also be expected to be associated with reduced risk of 
functional disability as well. Recently, a prospective cohort study in an elderly 
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Japanese population has reported that green tea consumption was independently 
associated with a lowered risk of incident functional disability based on a 
certification for long-term care insurance (LTCI), a mandatory social insurance 
which assists the daily living activities of frail and elderly persons. [153]. 
However, only the risk of incident functional disability was examined in this 
study and information on the other types of tea consumed was not collected. 
They did not measure objective performance tests. No study has yet investigated 
this association with respect to the consumption of black tea and performance-
based measures of physical function in the elderly. 
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CHAPTER 3. METHODS 
3.1 Subjects 
The Singapore Longitudinal Ageing Study (SLAS) is a prospective random 
sample cohort observational study of ageing and health among community-
dwelling elderly Singaporeans. During recruitment and baseline data collection 
between September 2003 and December 2005, all older adult residents aged ≥55 
years (Baseline N=2,804, 78% response rate, Follow-up N= 1850, 34 % 
response rate) were identified by door-to-door census in South East Singapore 
for participation in the study. Compared to non-respondents, the respondents 
were younger (mean age: 66.0; SD 7.7) years Vs 68.1 (SD 9.2), included more 
women (63.2% vs 47.8%), and more residents in higher end housing (29.7% vs 
9.0%). Residents, who were severely physically or mentally ill, and 
incapacitated to give informed consent or participate, were excluded. The study 
was approved by the National University of Singapore Institutional Review 
Board, and all respondents gave signed informed consent. Participants 
completed an extensive series of face-to-face interviews, assessments and tests 
which were performed by trained research nurses, in the language or dialect 
(English or Chinese) preferred by the participants and the reliability and validity 
of the data are monitored by data manager. The percentages of missing for 
different variables are hemoglobin (1.5), albumin (1.5), vitamin B12 (71.6), 
folate (71.6), homocysteine (71.6), green tea drinking (14.5), English and oolong 
tea drinking (34), POMA balance (2.9), POMA gait (2.9), BADL (3), IADL 
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(2.7), Knee extension strength (72.9), age( 1.5), GDS (1.8), MMSE (1.8), 
creatinine (2), BMI (1.7), gender (1.5), housing type (1.5), education (1.5). 
 
Study I: Cross-sectional and longitudinal study of the relationships between 
albumin, haemoglobin and physical function and performances 
The study population of study I consisted of 2,762 respondents who provided 
complete baseline data for albumin, haemoglobin and performance-based 
assessment of gait, balance and and 626 respondents for knee extension strength. 
Longitudinal analyses for instrumental ADL ability was performed for 1,829 
respondents with baseline and follow up assessments at 1-2 years (median=1.5 
years) were available for only instrumental ADL ability.  
 
Study II: Cross-sectional study of the relationships between Folate, Vitamin 
B12, Homocysteine and Physical Function and performances 
For the current study, we performed cross-sectional analyses on baseline data of 
a random one-in-three subsample of 796 respondents who had laboratory 
measurements for folate, B12, and homocysteine, and completed performance-
based assessments of gait and balance and self reports of instrumental activities 
of daily living (IADL).  
 
Study III: Cross-sectional study of the relationships between Tea consumption 
and physical function and performances 
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For the current study, we performed cross-sectional analyses of 2,398 
respondents for whom we had complete baseline data for tea consumption and 
performance-based assessments of gait, balance, basic and instrumental 
activities of daily living. 
 
3.2 Face-to-face questionnaire interviews, clinical measurements and 
assessments 
3.2.1 Socio-demographic data and substance use 
Socio-demographic data included age, gender and education (categorized as Nil, 
Primary, Secondary, Pre-University or Polytechnic, and University). Information 
on tobacco consumption was collected and categorized into current smokers, 
past smokers, or non- smokers. Information on alcohol consumption was 
classified as ‘never or rarely’, ‘less than 1 drink a week’, ‘more than 1 drink a 
week but less than 1 drink a day’, or ‘1 or more drinks a day’ accordingly. One 
drink was defined as a glass of wine, a shot of liquor or a ‘can’ of beer. 
 
Respondents completed an extensive series of face-to-face interviews, 
assessments and tests which were performed by trained research nurses, in the 
preferred language (English or Chinese or Malay) or dialect.  
 
3.2.2 Tea consumption information 
Detailed information on current habitual tea consumption was collected at 
baseline. Items on the tea questionnaire were designed according to the habitual 
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intake of common tea types among local elderly using indigenous references and 
terms such as: Ceylon/English tea, Chinese tea, and Green tea. Ceylon or 
English tea refers to black tea originating from South Asia (India and Sri Lanka) 
and these teas are usually consumed with sugar and/or milk. Chinese tea refers 
to both Chinese black tea and oolong tea, and is usually drunk plain.  
 
Coding of the frequency of tea consumption was as follow: 0=Never or rarely; 
1=Less than 1cup/wk; 2=More than 1 cup/wk but less than 1 cup/day; 3=1-2 
cups/day; 4= 3–5 cups/day; 5= 6–9 cups/day, and 6= 10 cups/day. One cup was 
defined as a standard small or regular cup used commonly in local cafes 
(approximately 215 ml). The total summed tea consumption score for each 
participant was used for analysis. For example, if a participant drinks English 
(black) tea=more than 1 cup/wk but less than 1 cup/day (coded as 2), Chinese 
black/oolong tea=1-2 cup/day (coded as 3) and never or rarely drank Green Tea 
(coded as 0), and the summed score will be 2 + 3 + 0 = 5. A respondent was 
classified as a non-tea consumer if the sum of the three scores was equal to zero; 
low consumer (score 1-3), and high consumer (score ≥4). 
 
3.2.3 Self-reported physical function  
Self-reported physical functional status was assessed using items from the 
Barthel’s scale (basic activities of daily living (BADL)[154] and the Lawton 
scale (Instrumental activities of daily living, IADL) [155], which had been 
validated in previous studies [156, 157]. The correlation coefficient between 
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BADL and POMA balance is 0.184, BADL and POMA gait is 0.378, IADL and 
POMA balance is 0.288 and IADL and POMA gait is 0.301 
respectively(p<0.01). The subjects’ abilities to perform the activities of daily 
living were categorized as follows: “unable to do at all” (score-0), “needed some 
assistance” (score-1), or “needed no help” (score-2). Higher summed BADL and 
IADL scores across different items represent higher function levels. IADL 
change score was calculated by subtracting the follow up score from the baseline 
score and analyzed as a continuous variable. Subjects were defined as having 
suffered a decline in IADL function if their IADL score fell by 1 or more points 
during the follow up period, and analyzed as a dichotomous variable.  
 
3.2.4 Physical Performance tests 
Gait and balance were measured by the performance oriented mobility 
assessment (POMA) tool [158]. Static sitting balance (rising from the sitting 
position without using hands) was assessed using graded scores by the need for 
assistance and the number of attempts; standing balance was assessed within the 
first five seconds after the subject’s sternum was gently pushed by the examiner, 
and when stance was stabilized. Staggering or excessive swaying of the subject 
was examined with the subject standing and his eyes closed. Steadiness and 
continuity of steps were observed with the subject turning in a complete 360 
degree circle. Gait assessment was performed with the subject walking 6 meters 
and returning quickly to the starting point, noting the ability to initiate walking 
and any hesitancy, step height and length, the lack of symmetry or inability to 
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clear the floor, step continuity, deviation in the path and walking stance. The 
POMA scores for balance and gait were tallied separately using standard scoring 
criteria, and a combined total score was determined.  
 
Testing of lower limb strength (knee extension muscle strength) was performed 
using a spring gauge attached to the subject’s leg using a webbing strap with a 
Velcro fastener. The force of the knee extensor was measured with the subject 
sitting on a tall chair with a strap around the leg 10 cm above the ankle joint, and 
the hip and knee joint angles positioned at 90 degrees. In 3 trials per muscle 
group, the subject attempts to pull against the strap assembly with maximal force 
for 2 to 3 seconds and the greatest force for each muscle group was recorded 
[159].  
 
3.2.5 Laboratory measurements 
Overnight fasting venous blood samples were transported to Singapore National 
University Hospital Referral Laboratory on ice within 2 h, and the plasma or 
serum was stored at -80°C before analysis. Serum level of albumin (g/L) was 
measured on Advia 2400 auto-analyzer (Bayer HealthCare Diagnostics) using 
Bromcresol Green (BCG) dye binding method (CV ranging from 1%-3%). The 
measurements of haemoglobin level (g/dL) were performed on the same 
automated system. Plasma fasting total homocysteine was measured by 
automated chemiluminescent enzyme immunoassay method (Diagnostic 
Products Corporation, Los Angeles, CA); the CV ranged from 4.1% to 10.4%. 
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Folate and vitamin B-12 was measured in serum by radioassay with an 
ElecsysFolate II reagent kit (CVs ranged from 6.1%to 13.8%) and an Elecsys 
Vitamin B-12 reagent kit (CVs ranged from 3.2% to 7.6%; Roche Diagnostic, 
Indianapolis, IN), respectively. Serum creatinine (umol/L) was measured by an 
enzymatic (Jaffe) method calibrated to the NIST LC-IDMS method 
recommended by the National Kidney disease Education Programme and 
traceable to NIST SRM967.  
 
3.2.6 Other variables 
Other information collected included age, gender, education, housing type, 
cigarette smoking status (current smokers, past-smokers, or non-smokers), 
alcohol consumption (at least 1 alcoholic drink daily versus nil), and 
hospitalization in the past 12 months. Body mass index (BMI) was calculated as 
kg/m2 from measured weight and height. 
 
Respondents were asked to report whether in the one year prior to the interview 
they were diagnosed and treated by a doctor for any one or more of a list of 
specific chronic medical conditions, which included coronary artery disease, 
heart failure, hypertension, diabetes mellitus, arthritis, hip fracture, cataract, 
asthma, chronic obstructive pulmonary disease (COPD) and other medical 
conditions specified by them. The presence of chronic medical disorders was 
corroborated by the use of appropriate medications (visually verified by research 
nurses from medication packages) and medical procedures such as coronary 
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angioplasty or bypass for specific conditions. In Study I, II and II, hypertension, 
heart disease, liver disease, kidney disease and diabetes mellitus were used as 
covariates in the data analysis. Hypertension was defined as systolic blood 
pressure of >140mmHg or diastolic blood pressure of >90mm Hg or a history of 
treatment for hypertension. Diabetes mellitus was defined as a fasting blood 
glucose concentration of ≥7.0 mmol/L or a history of treatment for diabetes 
mellitus. 
 
 In this thesis, we had analyzed data by using three different methods for 
adjusting a variable (co-morbidities): first, adjusted the total number of co-
morbidities as a continuous variable, second, adjusted by separate diseases and 
lastly, used stratification methods. All analyses showed that potential 
confounders eg. Co-morbidities: hypertension, cardiac, Diabetes Mellitus, and 
Kidney Failure were omitted because of collinearity. 
 
Cognitive performance was assessed by the Mini-Mental State Examination 
(MMSE) [160]. The local translated versions of the instrument with a cutoff of 
23/24 (97.5% sensitivity and 75.6% specificity, AUC 95%) used to determine 
cognitive impairment has been validated for local use in Singaporean older 
adults [161]. 
 
The presence of depressive symptoms was assessed using the 15-item Geriatric 
Depression Scale [162], a 15-item scale with scores ranging from 0 to 15, 
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whereby a higher score indicates more symptoms of depression. The GDS has 
been validated for use in local older population [163, 164] in detecting major 
depressive disorder (sensitivity=0.97 and specificity=0.95, area under 
curve=0.98); its internal reliability coefficient (Cronbach’s α) was 0.84.  
 
Physical activity score was computed from the summed score of the frequencies 
of participation in multiple categories of physical activities (Physical exercises, 
walking, active sports or swimming, taiji), measured on a 3-point Likert scale 
(0=never: less than once a month, 1=sometimes: once a month or more but less 
than once a week, 3=often: at least once a week).  
 
Social activities included attending religious services, visiting cinemas, 
restaurants, sports events, day/excursion trips, games/card playing, senior citizen 
club activities, social group activities such as karaoke and line dancing. 
Productive activities included gardening, painting, and other hobbies, preparing 
meals, shopping, community work and other employment or business. 
Continuous (summed score) variables were created for physical and 
social/productive activities.  
 
The covariates are selected as potential confounders according to literature [165-
168] and according to definition of confounding variable [169]. 
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CHAPTER 4. ALBUMIN, HAEMOGLOBIN AND PHYSICAL 
FUNCTION 
Study I: Cross-sectional and longitudinal study of the relationships between 
albumin, haemoglobin and physical function and performances 
 
4.1 Statistical Analysis 
Group comparisons of categorical and continuous variables were performed 
using chi-squared test or analysis of variance, as appropriate. In multiple linear 
regression and logistic regression analyses, POMA gait, POMA balance, knee 
extension strength, baseline IADL score, IADL change score (continuous 
variable) and IADL decline (dichotomous variable) were analyzed as dependent 
variables. Regression coefficient (b) or odds ratio (OR) of association for 
albumin and haemoglobin (continuous variables) were estimated in base models 
(Model 1: unadjusted), and adjusted in hierarchical models that controlled for 
age, gender, education, housing type, hypertension, heart disease, liver disease, 
kidney disease and diabetes mellitus, hospitalization in the past year, GDS score, 
MMSE score, body mass index, creatinine level, history of arthritis and hip 
fracture (Model 2); and finally with haemoglobin and albumin together (Model 
3).  
 
Baseline IADL score was significantly associated with serum albumin and 
haemoglobin and predicted future decline of physical function, however in some 
plausible situations, adjusting for baseline health status may inflate regression 
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coefficient estimates for the effect [170].In longitudinal analyses, therefore, the 
multivariate models included models (Model 3) with and without (Model 2) 
baseline IADL scores as a baseline covariate. In further analyses, subjects with 
IADL disability (needing any help in IADL) at baseline were excluded (Model 
5), to determine the effect of albumin and haemoglobin in well-functioning 
individuals in predicting incident cases of IADL functional decline. A 2-sided p 
value of less than 0.05 was considered statistically significant. All analyses were 




The mean age of the study respondents was 66 (SD=7.7), and 1430 (51.8%) had 
less than 6 years of schooling. 93.1 % are Chinese and 30.5 % are living in ≤3 
room apartment. Low albumin (<38 g/L) was present in 199 (7.2%) of the 
respondents and low haemoglobin (<12g/dl in females and <13g/dl in males) 
was found in 397 (14.4%).  
 
POMA scores, knee extension and IADL scores were lower in anemic (versus 
non-anaemic) and hypoalbuminemic (versus normoalbuminaemic) respondents 
(p < 0.05) (Table 1). Anemic and hypoalbuminemic respondents were also 
noted to have lower MMSE score, GDS score, increased age, lower socio-
economic status, more co-morbidities and hospitalizations. Mean BMI was 
lower and creatinine was higher in anaemic (versus non-anaemic) respondents. 
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Cross-sectional analyses (Table 2) showed that in the unadjusted base model 
(Model 1), albumin was significantly associated with POMA gait, POMA 
balance scores, and knee extension strength (p<0.01). Controlling for gender, 
age, education, housing type, hypertension, heart disease, liver disease, kidney 
disease and diabetes mellitus, hospitalization, GDS score, MMSE score, body 
mass index, creatinine level and history of arthritis and hip fracture (Model 2), 
albumin was positively associated with POMA balance score and knee extension 
strength (p<0.01). With further adjustments for haemoglobin (Model 3), albumin 
remained significantly associated with POMA balance score (B=0.05, p<0.01) 
and knee extension strength (B=0.70, p<0.01). 
 
Haemoglobin was significantly associated with all objective physical function 
measures in the unadjusted model (p<0.01), but only the association with POMA 
balance score (b=0.09, p=0.04) remained statistically significant when all 
potential confounding variables and albumin were adjusted for in model 3. 
(Table 2) 
 
From follow up, 10% of respondents (n=182) showed a decline in IADL. 
Longitudinal analyses (Table 3) showed that albumin was significantly 
associated with IADL decline (OR = 0.87, 95% CI = 0.83-0.92) in the 
unadjusted base model (Model 1). Controlling for gender, age, education, 
housing type, hypertension, heart disease, liver disease, kidney disease and 
diabetes mellitus, hospitalization, GDS score, MMSE score, body mass index, 
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creatinine level and history of arthritis and hip fracture (Model 2), albumin was 
significantly associated with IADL decline (OR = 0.92, 95% CI = 0.87-0.97). 
Further adjustments for baseline IADL scores (Model 3) and haemoglobin 
(Model 4) showed that albumin remained significantly associated with IADL 
decline (OR= 0.92, 95% CI = 0.87-0.97). In further analyses that excluded 
subjects with IADL disability at baseline, we obtained similar results (Model 5. 
OR = 0.91, 95% CI = 0.85-0.98). Similar results were obtained when the IADL 
change score (continuous variable) was used as the dependent variable 
(regression coefficient was -0.02 (SE= 0.008, P=0.01 in the final model).  
 
In order to re-analysis by stratifying according to presence of co-morbidities, the 
data set is splitted into three studies, study I (albumin, haemoglobin and physical 
functional performances) and study II (homocysteine, folate, vitamin B12 and 
physical functional performances) and study III (tea consumption and physical 
functional performances). Furthermore, we analyze based on with or without 
Hypertension, Heart disease, Diabetes Mellitus, Liver disease, and kidney 
disease. 
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Study I 
ALB& HB and physical functional performances 
By using hierarchical model in multiple linear regressions, we found out that the 
linear trend of blood bio-markers level associated with physical functional 
performances and also analyzed including interaction term.And to support this 




After stratification between hypertensive and non-hypertensive groups, we have 
found out that, in hypertensive group, higher albumin level is negatively 
associated with POMA Gait(B-0.007±SE0.005), p= 0.2and is positively 
associated with the other group (non-hypertensive)(B0.005±SE0.004), p= 
0.21.When one g/L of albumin is increased,0.007point of POMA Gait score 
decrease in hypertensive group and 0.005 point of score increase in the other 
group. 
 
Next, we have found that, in hypertensive group, higher albumin level is 
positively associated with POMA Balance(B0.034±SE0.03), p= 0.2, compared 
with the other group (non-hypertensive)(B0.059±SE0.02), p=<0.01. When one 
  41 
 
g/L of albumin is increased,0.034 point of POMA Balance score increase in 
hypertensive group and 0.059 in the other group. 
 
Next, we have found that, in non-hypertensive group, higher albumin level is 
positively associated with BADL (B0.006±SE0.005), p= 0.2 and with IADL (B-
0.021±SE0.02), p= 0.2. 
 
After stratification between with and without liver disease, we have found that, 
higher albumin level is positively associated with POMA Gait without liver 
disease (B0.001±SE0.003), p=0.69.  
 
After stratification between with and without liver disease, we have found that, 
higher albumin level is positively associated with POMA Balance without liver 
disease (B0.045±SE0.03), p=0.13.  
 
After stratification between with and without liver disease, we have found that, 
higher albumin level is positively associated with BADL without liver disease 
(B0.005±SE0.004), p=0.19.  
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After stratification between with and without liver disease, we have found that, 
higher albumin level is negatively associated with IADL without liver disease 
(B-0.017±SE0.02), p=0.27. 
 
Among 2762 subjects, we can only access 626 subjects for knee extension 
strength. Therefore, it cannot be done stratification analysis between with and 
without liver disease. 
 
After stratification between with and without diabetes disease, we have found 
that, higher albumin level is positively associated with POMA Gait without 
diabetes disease (B0.005±SE0.003), p=0.12.  
 
After stratification between with and without diabetes disease, we have found 
that, higher albumin level is positively associated with POMA Balance without 
diabetes disease (B0.07±SE0.03), p=0.02.  
 
After stratification between with and without diabetes disease, we have found 
that, higher albumin level is positively associated with BADL without diabetes 
disease (B0.004±SE0.003), p=0.17.  
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After stratification between with and without diabetes disease, we have found 
that, higher albumin level is negatively associated with IADL without diabetes 
disease (B-0.012±SE0.015), p=0.4. 
 
Among 2762 subjects, we can only access 626 subjects for knee extension 
strength. Therefore, it cannot be done stratification analysis between with and 
without diabetes disease. 
 
After stratification between with and without cardiac disease, we have found 
that, higher albumin level is positively associated with POMA Gait with cardiac 
disease (B0.01±SE0.01), p=0.36.  
 
After stratification between with and without cardiac disease, we have found 
that, higher albumin level is positively associated with POMA Balance with 
cardiac disease (B0.019±SE0.11), p=0.85.  
 
After stratification between with and without cardiac disease, we have found 
that, higher albumin level is negatively associated with BADL with cardiac 
disease (B-0.011±SE0.007), p=0.14.  
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After stratification between with and without cardiac disease, we have found 
that, higher albumin level is positively associated with IADL with cardiac 
disease (B0.019±SE0.04), p=0.67. 
 
After stratification between with and without cardiac disease, we have found 
that, higher albumin level is positively associated with knee extension strength 
with cardiac disease (B0.922±SE0.63), p=0.16. 
 
Next, we have found that, in hypertensive group, higher albumin level is 
positively associated with knee extension strength compared with the other 
group (non-hypertensive). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Albumin 
(p=0.1), and there is an association between Albumin and POMA balance 
(p<0.01). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Albumin 
(p=0.08), and there is an association between Albumin and POMA gait (p=0.9). 
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After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Albumin 
(p=0.6), and there is an association between Albumin and BADL (p=0.2). 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Albumin 
(p=0.09), and there is an association between Albumin and IADL (p=0.7). 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Albumin 
(p=0.6), and there is an association between Albumin and knee extension 
strength (p=<0.01). 
 
Therefore, it is possible that there is no modifier effect of chronic diseases on the 
association of Albumin and physical functional performances. 
 
Haemoglobin was not found to be significantly associated with IADL change 
score and IADL decline. Interaction between albumin and haemoglobin was 
explored, and no statistically significant interactions were found. 
 
HB 
After stratification between hypertensive and non-hypertensive group, we have 
found that, in hypertensive group,higher haemoglobin level is positively 
associated with POMA Gait (B0.012±SE0.013), p= 0.3 compared with the other 
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group (non-hypertensive) (B0.005±SE0.012), p= 0.7. When one g/L of 
haemoglobin is increased, 0.012 point of POMA Gait score increase in 
hypertensive group and 0.005 in the other group. 
 
Next, we have found that, in hypertensive group, higher haemoglobin level is 
positively associated with POMA Balance (B0.123±SE0.07), p= 0.08 compared 
with the other group (non-hypertensive) (B0.054±SE0.06), p= 0.3. When one 
g/dL of haemoglobin is increased, 0.123 point of POMA Balancescore increase 
in hypertensive group and 0.0.54in the other group. 
 
Next, we have found that, in hypertensive group, higher haemoglobin level is 
negatively associated with BADL (B-0.003±SE0.019), p= 0.9 and is positively 
associated with IADL (B0.049±SE0.08), p= 0.6. 
 
Next, we have found that, in hypertensive group, higher haemoglobin level is 
positively associated with knee extension strength (B1.118±SE0.76), p= 0.14 
compared with the other group (non-hypertensive) (B0.421±SE0.33)p= 0.2. 
When one g/dl of haemoglobin is increased 1.118 Kg of knee extension strength 
increase in hypertensive group and 0.42 Kg in the other group. 
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After stratification between with and without cardiac disease, we have found 
that, higher haemoglobin level is positively associated with POMA Gait without 
cardiac disease (B0.004±SE0.01), p=0.68.  
 
After stratification between with and without cardiac disease, we have found 
that, higher haemoglobin level is positively associated with POMA Balance 
without cardiac disease (B0.137±SE0.09), p=0.15.  
 
After stratification between with and without cardiac disease, we have found 
that, higher haemoglobin level is positively associated with BADL without 
cardiac disease (B0.017±SE0.01), p=0.18.  
 
After stratification between with and without cardiac disease, we have found 
that, higher haemoglobin level is positively associated with IADL without 
cardiac disease (B0.015±SE0.05), p=0.7. 
 
Among 2762 subjects, we can only access 626 subjects for knee extension 
strength. Therefore, it cannot be done stratification analysis between with and 
without cardiac disease. 
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After stratification between with and without diabetes disease, we have found 
that, higher haemoglobin level is negatively associated with POMA Gait without 
diabetes disease (B-0.0007±SE0.009), p=0.9.  
 
After stratification between with and without diabetes disease, we have found 
that, higher haemoglobin level is positively associated with POMA Balance 
without diabetes disease (B0.085±SE0.09), p=0.3.  
 
After stratification between with and without diabetes disease, we have found 
that, higher haemoglobin level is positively associated with BADL without 
diabetes disease (B0.012±SE0.009), p=0.17.  
 
After stratification between with and without diabetes disease, we have found 
that, higher haemoglobin level is negatively associated with IADL without 
diabetes disease (B-0.011±SE0.04), p=0.8. 
 
Among 2762 subjects, we can only access 626 subjects for knee extension 
strength. Therefore, it cannot be done stratification analysis between with and 
without diabetes disease. 
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After stratification between with and without liver disease, we have found that, 
higher haemoglobin level is positively associated with POMA Gait without liver 
disease (B0.004±SE0.009), p=0.6.  
 
After stratification between with and without liver disease, we have found that, 
higher haemoglobin level is positively associated with POMA Balance without 
liver disease (B0.08±SE0.09), p=0.3.  
 
After stratification between with and without liver disease, we have found that, 
higher haemoglobin level is positively associated with BADL without liver 
disease (B0.013±SE0.01), p=0.2.  
 
After stratification between with and without liver disease, we have found that, 
higher haemoglobin level is positively associated with IADL without liver 
disease (B0.02±SE0.04), p=0.6. 
 
Among 2762 subjects, we can only access 626 subjects for knee extension 
strength. Therefore, it cannot be done stratification analysis between with and 
without liver disease. 
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After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Hb 
p=0.2), and there is an association between Hb and POMA balance (p=0.09). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Hb 
p=0.09), and there is an association between Hb and POMA gait (p=0.6). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Hb 
(p=0.6), and there is an association between Hb and BADL (p=0.8). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction term of presence of any chronic diseases and Hb 
(p=0.06), and there is an association between Hb and IADL (p=0.19). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and Hb 
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(p=0.7), and there is an association between Hb and knee extension strength 
(p=0.06). 
 
Therefore, it is possible that there is no modifier effect of chronic diseases on the 
association of Hb and Knee Extension Strength, BADL, IADL, and POMA gait, 
but there is modifier effect of chronic diseases on the association of Hb and 
POMA balance. 
 
[Data not shown in table] 
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Table 1 Description of the study respondents (n= 2762) 
Variables 
Total    Low Albumin (<38 g/L)    Anemia 
a
 
  Yes (N=199)  No (N=2563)  P
b
  Yes (397)  No (2365)  P
b
 
Haemoglobin (g/dL),  13.5±1.4(6.5-18.6)  12.6±1.6 (6.5-16.9)  13.6±1.3 (8.5-18.6)  <0.01  11.5±0.9 (6.5-12.9)  13.8±1.1 (12-18.6)  <0.01 
Anemia, N (%) 397(14.4)  74(37.2)  323(12.6)  <0.01  -  -  - 
Albumin (g/L) 42.2±3.2(30-54)  35.9±1.5 (30-37)  42.7±2.8 (38-54)  <0.01  40.7±3.6 (30-52)  42.4±3.1 (31-54)  <0.01 
Low Albumin (<38 g/L), N (%) 199(7.2)  -  -  -  74(18.6)  125 (5.3)  <0.01 
Age 65.9±7.7(55-97.6)  70.7±9.3 (55.1-95.7)  65.6±7.4 (55-97.6)  <0.01  69.6±9.1 (55.1-97.1)  65.4±7.2 (55-97.6)  <0.01 
Gender (female), N (%) 1744(63.1)  125(62.8)  1619 (63.2)  0.9  257(64.7)  1487 (62.9)  0.47 
Education (primary and below), N (%) 1430(51.8)  130 (65.3)  1300 (50.7)  <0.01  246 (62)  1184(50.1)  <0.01 
Housing type (≤3 rooms), N (%) 855(31)  117 (58.8)  738 (28.8)  <0.01  163 (41.1)  692 (29.3)  <0.01 
Number of co morbidities 2.3±1.5(0-9)  2.4±1.7 (0-6)  2.3±1.5 (0-9)  0.36  2.6±1.6 (0-9)  2.3±1.4 (0-9)  <0.01 
Hypertension, N (%) 1017(36.8)  68 (34.2)  949 (37)  0.4  154 (38.8)  863 (36.5)  0.38 
Heart Disease, N (%) 222(0.08)  29 (14.6)  193 (7.5)  <0.01  41 (10.3)  181 (7.7)  0.07 
Diabetes Mellitus, N (%) 492 (17.8)  43 (21.6)  449 (17.5)  0.15  101 (25.4)  391 (16.5)  <0.01 
Renal disease, N (%) 22(0.008)  3 (1.5)  18 (0.7)  0.21  10 (2.5)  11 (0.5)  <0.01 
Liver diseases, N (%) 13(0.005)  2(1)  11(0.4)  0.25  1 (0.3)  12 (0.5)  0.49 
Hospitalized in past year, N (%) 110(0.04)  14 (7.0)  96 (3.7)  0.02  28 (7.1)  82 (3.5)  <0.01 
Non-smoker, N (%) 2302(83.3)  148 (75.1)  2154 (84.1)  <0.01  333 (84.1)  1969(83.4)  0.8 
Former smoker, N (%) 284(10.3)  25 (12.7)  259 (10.1)  <0.01  41 (10.4)  243 (10.3)  0.8 
Current smoker, N (%) 172(6.2)  24 (12.2)  148(5.8)  <0.01  22 (5.6)  150(6.4)  0.8 
Alcohol Drinker, N (%) 295(10.7)  24 (12.1)  271(10.6)  0.5  44(11.1)  251(10.6)  0.76 
BMI (kg/m2) 23.8±3.8(12.5-44.9)  23.6±4.9 (13.1-44.9)  23.8±3.7 (12.5-43.9)  0.5  22.5±3.8 (13.6-44.7)  23.9±3.7 (12.5-44.9)  <0.01 
Creatinine(umol/L) 80.6±25.7(34-468)  80.9±23.8 (38-166)  80.6±25.9 (34-468)  0.8  86.4±39.7 (38-468)  79.6±22.4 (34-388)  <0.01 
History of arthritis, hip fracture, N (%) 479(17.3)  32 (16.1)  447 (17.4)  0.7  68 (17.1)  411 (17.4)  0.9 
MMSE total score 26.9±3.6(3-30)  24.7±5.7 (4-30)  27.1±3.3 (3-30)  <0.01  25.6±4.6 (5-30)  27.1±3.4 (3-30)  <0.01 
MMSE <24, N (%) 347(12.5)  52 (26.5)  295 (11.5)  <0.01  92 (23.4)  255(10.8)  <0.01 
GDS total score 1.9±2.7(0-15)  2.6±3.5 (0-15)  1.8±2.7 (0-15)  <0.01  2.4±3 (0-15)  1.8±2.7 (0-15)  <0.01 
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(Cont.) Table 1. Description of the the study respondents (n= 2762) 
Variables Total 











   Yes (N=199)  No (N=2563)  P
b
  Yes (397)  No (2365)  P
b
 
GDS>=5, N (%) 361(13)  40 (20.2)  321 (12.6)  <0.01  73 (18.5)  288(12.2)  <0.01 
POMA total score at baseline 32.5±3.5(0-35)  30.4±5.7 (1-35)  32.6±3.2 (5-35)  <0.01  31.1±4.7 (5-35)  32.7±3.2 (1-35)  <0.01 
POMA Gait score 8.9±0.6(0-9)  8.7±1.2 (0-9)  8.9±0.5 (0-9)  <0.01  8.8±0.9 (0-9)  8.9±0.5 (0-9)  <0.01 
POMA Balance score 23.5±3.2(0-26)  21.5±5.2 (0-26)  23.7±2.9 (4-26)  <0.01  22.3±4.2 (1-26)  23.7±2.9 (0-26)  <0.01 
Knee extension (kg) 27.2±12.1(6-212)  21.9±8.3 (8-37)  27.4±12.1 (6-212)  0.01  23±8.5 (8-46)  27.7±12.3 (6-212)  <0.01 
IADL score 13.3±2.0(0-14)  12.3±3.6 (0-14)  13.4±1.8 (0-14)  <0.01  12.97±2.8 (0-14)  13.4±1.8 (0-14)  <0.01 
              
 
Figures shown are mean±SD (range) or N (%) a WHO criteria: <12g/dl for women and <13 g/dl for men b Independent sample t test for continuous variables, chi-square test for categorical variables 
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Table 2 Cross-sectional analysis: associations of albumin and haemoglobin with physical performance measures 
  POMA gait   POMA balance   Knee Extension Strength 
  B ± SE  Beta p  B ± SE Beta p  b ± SE Beta P 
Albumin                       
Model 1 0.02 ± 0.003  0.09 <0.01  0.18 ± 0.02 0.19 <0.01  1.1 ± 0.2 0.3 <0.01 
Model 2 0.002 ± 0.003 0.01 0.6  0.06 ± 0.02 0.06 <0.01  0.8 ± 0.1 0.2 <0.01 
Model 3 0.001 ± 0.003 0.007 0.7  0.05 ± 0.02 0.05 <0.01  0.7 ± 0.1 0.2 <0.01 
Haemoglobin            
Model 1 0.05±0.008 0.1 <0.01  0.4±0.04 0.16 <0.01  3±0.3 0.3 <0.01 
Model 2 0.009±0.009 0.02 0.3  0.1±0.04 0.05 <0.01  1.01±0.3 0.12 <0.01 
Model 3 0.008 ± 0.009 0.02 0.4   0.09±0.04 0.04 0.04   0.6±0.3 0.07 0.07 
 
MMSE= Mini-mental state examination, GDS= Geriatric Depression Score, POMA=Performance oriented mobility assessment, IADL= Instrumental Activity of 
Daily Living, B= unstandardized coefficients, SE= standard error, Beta= standardized coefficients 
Model 1: Unadjusted 
Model 2: Adjusted for age, gender, education, housing type, , hypertension, heart disease, Diabetes mellitus, renal disease, liver disease, hospitalization in past 
year; GDS score, MMSE score, body mass index(BMI), creatinine level and history of arthritis and hip fracture; 
Model3: Adjusted for variables in Model 2 plus haemoglobin (for albumin) or albumin (for haemoglobin) 
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Table 3 Longitudinal analysis: association of baseline albumin and haemoglobin level with  
  IADL decline (N=1829) 
    IADL change   IADL decline* 
    B± SE Beta p   OR 95% CI P 
Albumin         
Model 1  -0.03 ± 0.01 -0.06 <0.01  0.87 0.83 - 0.92 <0.01 
Model 2  -0.02 ± 0.007 -0.05 <0.01  0.92 0.87 – 0.97 <0.01 
Model 3  -0.03 ± 0.01 -0.06 <0.01  0.92 0.87 – 0.97 <0.01 
Model 4  -0.02 ± 0.007 -0.05 0.01  0.92 0.87 – 0.97 <0.01 
Model 5  -0.02 ± 0.008 -0.07 0.01  0.91 0.85 – 0.98 0.01 
         
Haemoglobin         
Model 1  -0.02 ± 0.02 -0.02 0.5  0.94 0.84 – 1.11 0.3 
Model 2  -0.02 ± 0.03 -0.02 0.6  0.95 0.83 – 1.11 0.5 
Model 3  -0.02 ± 0.03 -0.02 0.4  0.95 0.83 – 1.11 0.5 
Model 4  -0.001 ± 0.03 -0.001 0.9  0.99 0.86 – 1.15 0.9 
Model 5   -0.02 ± 0.02 -0.03 0.4   0.94 0.79 – 1.13 0.5 
 
* Defined as ≥1 point decline on IADL score during follow-up period 
Model 1:  Unadjusted 
Model 2: Adjusted for age, gender, education, housing type, hypertension, heart disease, Diabetes mellitus,  
  renal disease, liver diseases, hospitalization in past year; GDS score, MMSE score, body  
  mass index(BMI) , creatinine level and history of arthritis and hip fracture 
Model 3: Adjusted for variables in Model 2 plus IADL score at baseline  
Model 4: Adjusted for variables in Model 2 plus haemoglobin (or albumin)  
Model 5: Excluded subjects with IADL disability at baseline (N=1435), adjusted for variables in Model 4.  
  (Baseline IADL score not included). 
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4.3 Discussion 
The results of our study found that serum albumin was linearly associated with 
POMA balance score, knee extension strength, IADL change score and IADL 
decline at follow-up. Serum haemoglobin was significantly associated with 
POMA balance score only.  
 
Our findings were in line with previous studies that reported an association 
between albumin or haemoglobin with physical function in the elderly [54, 55, 
61-63, 64]. The associations we observed remained statistically significant after 
adjusting for hypertension, heart disease, diabetes mellitus, renal failure, liver 
diseases, cognitive function, depressive symptoms and other variables, which 
suggests that the relationships are not due to other chronic diseases.  
 
The observed associations of albumin and haemoglobin with physical function 
suggest that effects across the whole range of values of these continuous 
variables are in line with previous findings [55, 61]. Albumin was found to be 
associated with decreased physical function in healthy community dwelling 
older adults, and the use of conventional clinical cutoff values for albumin or 
haemoglobin might therefore not be applicable in healthy community dwelling 
older adults who are at risk of functional decline. Among well-functioning 
individuals, lower level of albumin in particular were found to predict future 
risks of functional decline, suggesting that they are potentially useful risk 
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markers of physical functional decline in older adults. Longitudinal analyses 
(Table 3) showed that albumin was significantly associated with IADL decline.  
 
Furthermore, our results in regression models that controlled simultaneously for 
both albumin and haemoglobin suggested that albumin had clearly more 
pronounced effects on physical function as compared with haemoglobin. This 
was clearly most evident in longitudinal analyses in which albumin, but not 
haemoglobin, was found to be significantly associated with IADL decline.  
 
This is the first study that has examined the independent associations of albumin 
and haemoglobin with physical function in community-living older adults. 
Previous studies [61-63, 64] have not adjusted for albumin when they examined 
the association between haemoglobin and physical function. In these studies, 
therefore, the actual effective strength of the association between haemoglobin 
and physical function could be less than reported. Albumin also reflects 
underlying general health conditions such as liver disease, kidney disease. 
Hence, a low albumin level in elderly may not necessarily be attributable only to 
poor nutrition. 
 
The association between serum albumin and physical function may be explained 
by two inter-related biological mechanisms. Firstly, albumin concentration is 
associated with age-associated skeletal muscle loss (sarcopenia) in older persons 
[65]. Increased muscle breakdown and muscle depletion lead to decline in 
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muscle strength, which could mediate the observed albumin-physical function 
associations. Secondly, albumin is a negative acute phase protein that decreases 
with systemic inflammation and is viewed as a marker of chronic inflammation. 
Since pro-inflammatory cytokines may cause muscle atrophy and has been 
associated with physical disability [67] or function decline [56], the observed 
association between albumin and physical function is also partly explained by 
chronic inflammation. 
 
Since pro-inflammatory cytokines affect hematopoiesis, anemia in old age due 
to chronic inflammation may arguably explain the association of haemoglobin 
with physical limitations [60]. Our analysis adjusting for albumin (as a surrogate 
marker of inflammation) [171] suggests that the observed association between 
haemoglobin and physical imitations may be mediated by other non-
inflammatory mechanisms. More likely, the relationship between haemoglobin 
and physical function may be secondary to the effects of fatigue, weakness, poor 
muscle oxygenation, and low level of physical activity that was associated with 
anemia [63, 68, 69].  
 
The strengths of this study included a large population-based sample and the use 
of both objective and subjective measures to assess physical function limitations 
and ADL disability. The multivariate analysis controlled for a wide range of 
potential confounders hence the results appear robust and reliable. A limitation 
of the study was that physical performance tests were not repeated at follow up, 
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hence we were only able to demonstrate longitudinal relationship for albumin 
with IADL decline. Also, pro-inflammatory cytokines (such as IL-6, C-reactive 
protein, TNF-a, and others) were not measured, hence we were not able to 
examine the specific mediating roles of those cytokines in physical functional 
status and decline. Also we did not include upper extremity measures of physical 
function or lean body mass and other anthropometric measures of nutrition and 
sarcopenia. Haemoglobin is only associated with POMA balance and marginally 
associated with knee extension strength (p=0.07). Thus, the present study might 
not have enough power to detect an association with haemoglobin and knee 
extension strength. POMA balance score range score is (0-26) and gait score 
range is narrow (0-9) .There is no association with POMA gait and albumin and 
haemoglobin, it may be explained by ceiling effect for POMA gait. However we 
cannot rule out the possibility that haemoglobin is only associated with Balance. 
 
The significant associations of serum albumin and haemoglobin with physical 
function in community living older adults have practical implications for the 
prevention of physical disability in old age. The findings suggest that low levels 
of albumin and haemoglobin are potentially useful risk markers of physical 
functional decline in older adults. Further research should investigate whether 
improvements in the levels of albumin and haemoglobin alter the level of 
functional disability and risk of functional decline.  
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CHAPTER 5. FOLATE, VITAMIN B12, HOMOCYSTEINE AND 
PHYSICAL FUNCTION 
Study II: Cross-sectional study of the relationships between Folate, Vitamin 
B12 ,Homocysteine and Physical Function and performances 
 
5.1 Statistical analysis 
Group comparisons of categorical and continuous variables were performed 
using chi-squared tests or analyses of variance, as appropriate. In multiple 
regression analyses, POMA gait, POMA balance, IADL score were analyzed as 
dependent variables. Regression coefficients (unstandardized B and standardized 
β) for folate, vitamin B12, homocysteine as continuous variables were estimated 
in base models (Model 1: unadjusted), and adjusted in hierarchical models that 
controlled for age, gender, education, housing type, hypertension, heart disease, 
diabetes mellitus, hospitalization in past year, history of arthritis and hip 
fracture, GDS score, MMSE score, body mass index (BMI), creatinine level, 
albumin, haemoglobin, and physical activity score (Model 2); and in the final 
model with folate, vitamin B12 and homocysteine together (Model 3).  
 
Mean adjusted values of physical performance variables were estimated in 
general linear models from marginal means for quartile categories of 
homocysteine, folate and B12 (Figure 1). The distribution of POMA gait, 
POMA balance, and IADL data were skewed. Cubic transformed values for 
normal approximation, as well as untransformed values of these dependent 
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variables were attempted in significance testing. As there were no differences in 
results using both approaches, the results based on untransformed values are 
presented in the tables for greater ease of interpretation.  
 
A 2-sided p value of less than 0.05 was considered statistically significant. All 
analyses were carried out with SPSS statistical software version 18.0 (SPSS, 
Inc., Chicago, Illinois).  
 
5.2 Results 
Table 4 displays characteristics of the study sample. The mean age of the study 
participants was 65.6 (SD = 7.4), and a larger proportion were women (61.4%). 
More than half of the participants had less than 6 years of schooling (57.9%). 
The mean (±SD) number of medical morbidities was 2.3 ± 1.4. The levels of 
homocysteine were correlated with folate (r = -0.312 p<0.001) and B12 (r = -
0.273, p<0.001). None of the participants showed evidence of gross folate 
deficiency (<5.0 nmol/L), and only 4 had borderline deficiency (5.0 - 6.9 
nmol/L). Twenty four participants (5%) showed vitamin B12 deficiency (below 
179 pmol/L). 
 
In regression analyses (Table 5), homocysteine showed significant negative 
associations with POMA balance, POMA gait scores and IADL (p<0.05). The 
associations remained statistically significant (p<0.05) when controlled for 
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confounding by gender, age, education, housing type, hypertension, heart 
disease, diabetes mellitus, hospitalization, GDS score, MMSE score, body mass 
index, creatinine level, arthritis and hip fracture, serum albumin and 
haemoglobin and physical activity (Model 2) and additionally for folate and 
vitamin B12 (Model 3). See also Figure 1.  
 
Serum folate showed a significant positive association only with POMA balance 
scores (p<0.01) in the unadjusted model (Model 1), and remained significantly 
associated with POMA balance score in models that further adjusted for other 
variables (Model 2) and additionally for serum vitamin B12 (Model 3) 
(standardized beta=0.066, p=0.038).  
 
Folate is associated with POMA balance (B±SE 0.01±0.007 p=0.19), POMA 
gait (B±SE -0.001±0.001 p=0.2), and IADL (B±SE -0.01±0.004 p=0.02), 
respectively, in chronic disease free group (statistically significant). 
 
Folate is associated with POMA balance (B±SE 0.021±0.013 p=0.09), POMA 
gait (B±SE 0.003±0.002 p=0.06), and IADL (B±SE 0.01±0.008 p=0.1), 
respectively, in the subgroup presence of any disease. 
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After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and folate 
(p=0.2), and there is an association between folate and POMA balance (p=0.1). 
 
After including interaction terms, I have found that it is statistically significant 
in interaction terms of presence of any chronic diseases and folate (p=0.02), and 
there is an association between folate and POMA gait (p=0.09). 
 
After including interaction terms, I have found that it is statistically significant 
in interaction terms of presence of any chronic diseases and folate (p=0.05), and 
there is an association between folate and IADL (p=0.03). 
 
Therefore, it is possible that there is no modifier effect of chronic diseases on the 
association of folate and POMA balance but there is modifier effect of chronic 
diseases on the association of folate and POMA gait and IADL. 
 
Vitamin B12 is associated with POMA balance (B±SE -0.001±0.0005 p=0.05), 
POMA gait (B±SE -0.00005±0.00006 p=0.4), and IADL (B±SE 0.0004±0.0003 
p=0.19), respectively, in chronic disease free group (statistically significant). 
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B12 is associated with POMA balance (B±SE -0.001±0.001 p=0.4), POMA gait 
(B±SE -0.0002±0.0001 p=0.05), and IADL (B±SE -0.001±0.0005 p=0.1), 
respectively, in the subgroup presence of any disease. 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms and Vitamin B12 (p=0.3), and there is an 
association between B12 and POMA balance (p=0.1). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms and Vitamin B12 (p=0.8), and there is an 
association between B12 and POMA gait (p=<0.01). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms and Vitamin B12 (p=0.09), and there is an 
association between B12 and BADL (p=0.04). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms and Vitamin B12 (p=0.14), and there is an 
association between B12 and IADL (p=0.9). 
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Therefore, it is possible that there is no modifier effect of chronic diseases on the 
association of Vitamin B12 and physical functional performances. 
 
HCY is associated with POMA balance (B±SE -0.054±0.02 p=0.03), POMA 
gait (B±SE 0.00006±0.002 p=0.9), and IADL (B±SE -0.004±0.02 p=0.8), 
respectively, in chronic disease free group (statistically significant). 
 
HCY is associated with POMA balance (B±SE -0.017±0.03 p=0.6), POMA gait 
(B±SE -0.029±0.004 p=<0.01), and IADL (B±SE -0.07±0.02 p=<0.01), 
respectively, in the subgroup presence of any disease. 
 
After including interaction terms, I have found that there is no statistically 
significant in interaction terms and HCY (p=0.4), and there is an association 
between HCY and POMA balance (p=0.04). 
 
After including interaction terms, I have found that there is statistically 
significant in interaction terms and HCY (p=<0.01), and there is an association 
between HCY and POMA gait (p=<0.01). 
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After including interaction terms, I have found that there is statistically 
significant in interaction terms and HCY (p=0.02), and there is an association 
between HCY and IADL (p=0.1). 
 
Therefore, it is possible that there is no modifier effect of chronic diseases on the 
association of HCY and POMA balance but there is modifier effect of chronic 
diseases on the association of HCY and POMA gait and IADL. 
[Data not shown in table] 
 
Serum vitamin B12 was not significantly associated with POMA balance, 
POMA gait or IADL scores. Interaction between serum folate and plasma total 
homocysteine was explored, and no statistically significant interactions were 
found.
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Table 4 Description of the study participants (N=796) 
Variables Value 
Covariates  
Age in years 65.6±7.4 (55-98)
1
 
Gender (female), N (%) 489(61.4) 
Education (Primary and below), N (%) 461 (57.9) 
Current and Ex smoker, N (%) 136 (17.1) 
Regular alcohol drinker, N (%) 87(10.9) 
Number of co-morbidities 2.3±1.4 (0-9) 
Hypertension, N (%) 306 (38.4) 
Heart Disease, N (%) 71(8.9) 
Diabetes Mellitus, N (%) 153 (19.2) 
Hospitalised in past year, N (%) 30 (3.8) 
Housing type (≤3 rooms), N (%) 259 (32.5) 
History of arthritis or hip fracture, N (%) 121 (15.2) 
MMSE total score 26.9±3.1 (7-30) 
MMSE <24, N (%) 107(13.4) 
GDS total score 2.2 ± 2.8 (0-15) 
GDS>=5, N (%) 132 (16.6) 
BMI kg/m
2
 23.8 ± 3.7 (12.5-40.6) 
Creatinine (µmol/L) 81.7 ± 34.9 (44-791) 
Albumin (g/L) 41.9 ± 3.3 (31-53) 
Haemoglobin (g/dL) 13.4 ± 1.3 (8.4-17.4) 
Folate (nmol/L) 24.1 ± 12.6 (6.7-90.8) 
Vitamin B12 (pmol/L) 406.3 ± 194.7 (35-1476) 
Homocysteine (µmol/L) 13.5 ± 5.1 (5.5-60.1) 
POMA Gait score 8.9 ± 0.3 (5-9) 
POMA Balance score 23.8 ± 2.5 (13-26) 
IADL score 13.4 ± 1.5 (3-14) 
Folate Borderline deficiency <6.9 nmol/L
2
, N (%)  4 (0.3)  
POMA Gait 9 ± 0 
POMA Balance 24 ± 2.8 
IADL 14 ± 0 
Vitamin B12 deficiency < 179 pmol/L
 2
, N (%) 24 (5.0) 
POMA Gait 8.9 ± 0.7 
POMA Balance 23.5 ± 2.7 
IADL 13.4 ± 1.3 
1 
Figures shown are mean ± SD (range), unless otherwise indicated
 
2
 National University Health System Referral Laboratory Reference 
SD= Standard deviation , BMI= Body Mass Index, MMSE= Mini-mental state examination,  
GDS= Geriatric Depression Score, POMA=Performance oriented mobility assessment, 
IADL= Instrumental Activity of Daily Living  
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Table 5 Regression analyses: association between homocysteie, folate, and vitamin B12 with physical performance and disability measures 
 Balance  Gait  IADL 
  b ± SE beta P   b ± SE beta P   b ± SE beta P 
                       
Homocysteine (per µmol/L)                        
Model 1 -0.12±0.02 -0.24 <0.01   -0.02±0.002 -0.27 0.02   -0.07±0.01 -0.25 <0.01 
Model 2 -0.04±0.02 -0.07 0.04   -0.01±0.002 -0.25 <0.01   -0.04±0.01 -0.13 <0.01 
Model 3 -0.04±0.02 -0.07 0.04   -0.02±0.002 -0.29 <0.01   -0.04±0.01 -0.15 <0.01 
            
Folate (per nmol/L)                       
Model 1 0.021± 0.007 0.107 0.003   -0.0001±0.001 -0.007 0.85   -0.001±0.004 -0.01 0.77 
Model 2 0.013±0.006 0.063 0.047   -0.0004±0.001 -0.02 0.59   -0.004±0.004 -0.03 0.31 
Model 3 0.013±0.006 0.066 0.038   -0.0003±0.001 -0.01 0.75   -0.004±0.004 -0.04 0.31 
                        
Vitamin B12 (per 1000*pmol/L)                       
Model 1 -0.20±0.46 -0.02 0.66   -0.056±0.054 -0.030 0.39   0.13±0.27 0.02 0.64 
Model 2 -0.28±0.41 -0.02 0.50   -0.11±0.052 -0.075 0.04   0.0009±0.25 0.0001 0.99 
Model 3 -0.37±0.41 -0.03 0.37   -0.10±0.052 -0.074 0.05   0.029±0.26 0.004 0.91 
            
 
Linear regression analysis (hierarchical model) 
* b ± SE converted to per 1,000 pmol/L units  
Model 1: Unadjusted 
Model 2: Adjusted for age, gender, education, housing type, number of co morbidities, hospitalization in past year, history of 
arthritis and hip fracture, GDS score, MMSE score, body mass index(BMI), creatinine level, albumin, haemoglobin, and 
physical activity 
Model 3: Adjusted for variables in Model 2 plus Vitamin B12 for folate (and vice versa) or folate and B12 (for homocysteine)
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Figure 1 Levels of adjusted mean of POMA balance, gait and IADL by quartiles of homocysteine and folate. 
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5.3 Discussion 
Our findings firmly supported previous studies, suggesting a negative 
association between hyper-homocysteinaemia and physical performance and 
functional decline in older persons. The estimates of the strength of association 
were robust from multivariate analyses. There was very modest attenuation of 
the magnitude of regression coefficients with adjustment for folate and B12 in 
the multivariate models. Serum folate was found to be positively associated only 
with performance on balance tests. This association with balance control has not 
been reported in previous studies. Furthermore, we examined the role of B12, 
and found no support of an independent association with physical performance 
and functional disability.  
 
Previous studies have reported inconsistent findings of the relationships between 
folate and/or B12 with risks of osteoporosis, hip fractures and falls, or physical 
functional performance. Among the few studies that examined folate, B12 
and/or homocysteine in combination, one study suggested that low serum folate 
was responsible for the observed association between homocysteine and risk of 
osteoporotic fracture, [110] another showed that folate was independently 
associated with hip fracture in women [111] and falls [112] in elderly persons. 
Other studies have reported that the associations of high homocysteine in bone 
mineral density and osteoporosis were greatly attenuated after adjusting for 
folate, vitamin B6 and B12, [113] or that Hcy and vitamin B12, but not folate, 
were associated with osteoporosis [114]. Yet another study which measured 
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folate, B12 and homocyteine together have found that low vitamin B12 alone 
was significantly associated with composite grip strength, endurance, physical 
activity and walking speed measurements of frailty syndrome in community-
dwelling older women [115]. On the other hand, two studies of community-
living elderly persons that measured plasma homocysteine and B12 together, but 
not folate [108, 109], showed that high homocysteine was independently 
associated with lower physical performance in older women [108] or poorer 
sensory and motor peripheral nerve function [109], but failed to clearly establish 
the association between vitamin B12 and physical performance.  
 
These wide variations in findings may be explained by the heterogeneity in the 
study populations with respect to their exposure to folate, B12 or homocysteine 
risks and their nutritional and health status. In Singapore, enriched cereal grain 
products were fortified with folic acid .We have learned that various companies 
are fortified their products with folates individually This is reflected in the low 
rate of folate deficiency observed in the study sample. It may also explain the 
observed lack of association of folate with gait and instrumental daily activities 
performance, although we were able to observe a significant association of folate 
with physical balance. The community-based setting of the study, the younger 
age and relatively better functioning status (with fewer frail individuals) of this 
study population should be noted. Previous studies of older and frail or nursing 
home elderly have reported significant associations of B12 with physical 
performance impairment [114] or folate with falls [111]. Our results therefore do 
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not exclude the possible adverse effects of low folate and/or B12 on physical 
performance and functional ability in older and frailer individuals.  
 
The strengths of this study included the large population sample of community-
living older persons, and the adjustment for a wide range of potential 
confounders in multivariate analysis, and the simultaneous determinations of 
homocysteine, folate and B12 levels together in the same sample. There are 
however limitations. The measurement of serum B12 is not as sensitive as 
methylmalonic acid in assessing B12 deficiency [172] hence a possible effect of 
B12 could not be excluded. Also, single measurements of serum folate may not 
be as accurate as red blood cell folate in measuring the body store of folate [72]. 
Our study did not include measures of vitamin B6 and thyroid function status 
which could represent undetermined sources of homocysteine variation and 
residual uncontrolled confounding, and bone mineral density, osteoporosis risk 
or distal mobility outcomes such as falls, which might be useful in corroborating 
the observed relationships. The cross-sectional design of the study also limits 
drawing direct causal inferences of the observed relationships. The independent 
effects of homocysteine, folate and B12 on physical function decline and 
mobility outcomes should be further investigated in future studies.  
 
The suggestion by our data of a negative association of elevated homocysteine 
with physical performance and functional disability is supported by known 
pathophysiological mechanisms of multisystem age-related problems associated 
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with homocysteine, [173] including oxidative damage via hydrogen peroxide 
formation, [174, 175] protein and deoxyribonucleic acid, and accelerated 
telomere loss. Oxidative damage of endothelial cells and intimal injury and 
fibrin deposition contribute to the development of endothelial lesions and 
atherosclerosis. The direct vascular effect of homocysteine in the brain and 
increased risk of cerebrovascular disease [176, 177] is supported by the 
association of elevated homocysteine with an increase in white matter 
hyperintensities, which have been shown to be correlated with poor cognitive 
[178, 178] and lower extremity function [180]. The presence of leukoaraiosis 
may interrupt frontal lobe circuits responsible for normal gait and balance and 
interfere with descending motor fibers arising from medial cortical areas, which 
are important for lower extremity motor control. There is also evidence to 
suggest that elevated homocysteine is associated with lower calf muscle mass in 
persons with peripheral arterial disease [106]. This may be due to homocysteine-
induced inflammatory responses, whereby inflammatory cytokines induce 
muscle proteolysis and inhibit repair after muscle tissue injury.  
 
The mechanism underlying the association between folate and physical 
performance found among our participants may in part be mediated through 
homocysteine. However, plasma folate levels have also been reported to be 
associated with cognitive function independently of homocysteine [85, 181, 182] 
and have been demonstrated to be mediated by vascular mechanisms through its 
association with the presence of white matter lesions [182]. Folate (as well as 
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B12) is closely involved in methylation reactions in the CNS which are 
necessary for the production of monoamine neurotransmitters, neuronal 
membrane phospholipids and nucleoprotein. Hence, folate deficiency can 
potentially influence various physiological processes in the neuromuscular and 
sensorimotor systems responsible for maintaining balance and postural stability. 
 
Our study provides firm support for the association of elevated homocysteine 
with poorer balance and gait performance and functional ability among 
community-living older persons, and also showed the independent association of 
folate with balance performance.  
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CHAPTER 6. TEA CONSUMPTION AND PHYSICAL FUNCTION  
Study III: Cross-sectional study of the relationships between Tea consumption 
and physical function and performances 
6.1 Statistical analysis 
Group comparisons of categorical and continuous variables were performed 
using chi-squared tests or analysis of variance, as appropriate. In linear 
regression analyses, POMA gait, POMA balance, BADL and IADL were 
analyzed as dependent variables. Regression coefficients (B) for total tea 
consumption score (continuous variable) were estimated in base models (Model 
1: unadjusted), and adjusted in hierarchical models: Model 2, which controlled 
for age, gender, education and housing type; Model 3, which additionally 
controlled for alcohol drinking, hospitalization in the past year, history of 
hypertension, history of arthritis and hip fracture, BMI, MMSE score and GDS 
score, haemoglobin, albumin and creatinine and physical activities score. and 
Regression coefficients (B) for ordinal categories of tea consumption were 
estimated in base models (unadjusted) and adjusted models which controlled for 
age, gender, education and housing type, hospitalized in past year, hypertension, 
heart disease, diabetes mellitus,, history of arthritis and hip fracture, BMI, 
MMSE score, GDS score, haemoglobin, albumin, creatinine, physical activities 
score, social and productive activities score, and coffee consumption (for tea), 
tea consumption (for coffee), ), green tea consumption (for black/oolong), 
black/oolong (for green tea) 
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A 2-sided p value of less than 0.05 was considered statistically significant. All 
analyses were carried out with SPSS statistical software version 18.0 (SPSS, 
Inc., Chicago, Illinois).  
 
6.2 Results 
Table 6 displays characteristics of the study sample. The mean age of the study 
participants was 66 (SD=7.59), and 1270 (53%) had less than 6 years of 
schooling. (Table 6) There were 908 (37.9%) non-tea consumers (total score = 
0), 844 (35.2 %) low tea consumers (total score = 1-3) and 646 (26.9 %) high tea 
consumers (total score ≥ 4). (Table-6) Among them, 934 consumed 
black/oolong tea, and 556 consumed green tea with or without black/oolong tea. 
Only 10 participants drank only green tea. The correlation coefficient between 
green tea and black tea drinking is 0.247. 
 
Participants with more frequent tea consumption were younger and more likely 
to be men, better educated, and live in larger housing units, and were less likely 
to be cognitively impaired or depressed, and showed higher mean levels of BMI, 
haemoglobin, albumin, and creatinine. We have found out that elder people, who 
are frequently consumed tea, have better cognitive function and less depressed. 
More frequent tea consumption was associated with more physical, social and 
productive activities, greater consumption of fish, vegetables and fruits, and 
alcohol consumption, but less frequent coffee consumption.  
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In the unadjusted base model (Model 1), total tea consumption was significantly 
associated with POMA gait, POMA balance scores, BADL and IADL scores 
(p<0.001). (Table 7) Controlling for age, gender, education, housing type 
(Model 2), alcohol drinking, hypertension, heart disease, diabetes mellitus, 
hospitalization, history of arthritis and hip fracture, body mass index, GDS 
score, MMSE score, haemoglobin, albumin, creatinine and physical activities 
score (Model 3), total tea consumption score was positively associated with 
POMA balance score (p<0.014), gait score (p=0.035), BADL (p=0.04) and 
IADL (p=0.008).  
 
Black/oolong tea consumers performed significantly better than non-tea 
consumers on POMA balance (p=0.01), POMA gait (p<0.04), BADL (p<0.04) 
and IADL (p=0.05) in fully adjusted models. (Table 8) Green tea consumers 
showed significantly better performance on all physical function measures in the 
unadjusted model, but the association was not significant in BADL when 
adjusted for all potential confounding variables in adjusted model. However, 
coffee consumption was not associated with any physical function measures. 
 
In linear regression analysis of black/oolong tea consumption in three categories 
of non (zero), low (score of 1-3) and high (score >=4), black/oolong tea was 
associated with POMA balance with P trend 0.01, marginally associated with 
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POMA gait (P trend 0.07) and IADL (P trend 0.07) (Table 9). Green tea high 
consumption was positively associated with POMA balance (B=0.72, SE=0.23 p 
trend 0.02), POMA gait score (B=0.09, SE=0.05 p trend =0.03) and IADL 
(B=0.29, SE=0.13 p=0.04) (Table 10). 
 
Tea consumption is associated with POMA balance (B±SE 0.035±0.02 p=0.1), 
POMA gait (B±SE 0.009±0.005 p=0.045), BADL (B±SE 0.004±0.006 p=0.5), 
IADL (B±SE 0.024±0.02 p=0.1) and knee extension strength (B±SE -
0.017±0.16 p=0.9), respectively, in chronic disease free group (statistically 
significant). 
 
Tea consumption is associated with POMA balance (B±SE 0.051±0.05 p=0.3), 
POMA gait (B±SE 0.007±0.009 p=0.4), BADL (B±SE 0.021±0.01 p=0.06), 
IADL (B±SE 0.04±0.02 p=0.1), and knee extension strength (B±SE 0.574±0.27 
p=0.04), respectively, in the subgroup presence of any disease. 
 
After including interaction terms, I have found that it is statistically significant 
in interaction terms of presence of any chronic diseases and tea score (p=0.03), 
and there is an association between Tea consumption and POMA balance 
(p=0.49). 
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After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and tea score 
(p=0.13), and there is an association between Tea consumption and POMA gait ( 
p=0.037). 
 
After including interaction terms, I have found that it is statistically significant 
in interaction terms of presence of any chronic diseases and tea (p=0.045), and 
there is an association between Tea consumption and BADL (p=0.6). 
 
After including interaction terms, I have found that it is statistically significant 
in interaction terms of presence of any chronic diseases and tea score (p=0.03), 
and there is an association between Tea consumption and IADL (p=0.04). 
 
After including interaction terms, I have found that it is not statistically 
significant in interaction terms of presence of any chronic diseases and tea score 
(p=0.06), and there is an association between Tea consumption and knee 
extension strength (p=0.9). 
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Therefore, it is possible that there is no modifier effect of chronic diseases on the 
association of tea consumption and POMA balance, BADL, and IADL but there 
is modifier effect of chronic diseases on the association of tea consumption and 
knee extension strength. 
[Data not shown in table] 
 
Figure 2 illustrates the increasing adjusted mean scores of POMA balance, 
POMA gait, BADL and IADL associated with ordinal categories (none, low, 
high) of tea consumption, all showing significantly positive trends (p <0.05). 
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Table 6 Basic description of the study population by level of all types of tea intake (N=2398) 
Variables Levels of tea intake in all types P 
None (n=908) Low ( n=844) High 
(n=646) 
 
     
Age 66.8 ±7.9 65.9 ± 7.6 64.9 ±7.1 <0.001 
Male, N (%) 255 (28.1)  314 (37.2) 304 (47.1) <0.001 
Current and Ex smoker 146 (16.1) 136 (16.1) 109 (16.9) 0.9 
Education more than 6 years 315 (34.7) 396 (46.9) 417 (64.6) <0.001 
Housing: >3 rooms apartment 563 (62.0) 585 (69.3) 517 (80.0) <0.001 
Hospitalized in past year 34 (3.7) 38 (4.5) 24 (3.7) 0.7 
Hypertension, N (%) 365 (40.2) 295(35) 221(34.2) 0.02 
Heart diseases, N (%) 75(8.3) 63(7.5) 52(8) 0.8 
Diabetes mellitus, N (%) 166(18.3) 139(16.5) 114(17.6) 0.6 
History of arthritis and hip fracture 117 (12.9) 119 (14.1) 73 (11.3) 0.3 
MMSE score 26.1 ± 4.1 27.2 ±2.9 27.8 ±2.5 <0.001 
MMSE <24 167 (18.4) 79 (9.4) 36 (5.6) <0.001 
GDS score 2.1 ± 2.9 1.9 ± 2.7 1.6 ± 2.6 0.003 
GDS>=5  139 (15.3) 117 (13.9) 71 (11.0) 0.05 
Body Mass Index, kg/m
2
 23.5 ± 3.8 23.4 ± 3.5 23.9 ± 3.3 0.01 
Hemoglobin (g/dL) 13.3 ± 1.3 13.5 ± 1.3 13.7 ± 1.4 <0.001 
Albumin (g/L) 41.9 ± 3.4 42.3 ± 3.2 42.5 ± 3.1 0.01 
Creatinine (µmol/L) 78.3 ±33.3 79.9 ± 22.2 83.9 ± 27.2 <0.001 
Physical activities score 2.2 ± 2.1 2.7 ± 1.9 2.9 ± 2 <0.001 
Daily alcohol Drinker 63 (6.9) 90 (10.7) 105 (16.3) <0.001 
Eat daily >2 portions of vegetable and fruits 827(91.4) 761 (90.4) 616 (95.5) 0.001 
Eat fish at least twice a week  768 (86.8) 722 (88.5) 563 (91.2) 0.03 
Coffee daily 623 (68.6) 552 (65.4) 398 (61.6) 0.02 
POMA Balance 23 ± 3.6 23.8 ± 2.7 24 ± 2.3 <0.001 
POMA Gait 8.86 ± 0.7 8.96 ± 0.3 8.96 ± 0.3 <0.001 
POMA Total score 31.9 ± 4.1 32.8 ± 2.9 33.1 ± 2.5 <0.001 
IADL 13.1 ± 2.2 13.5 ± 1.5 13.6 ± 0.9 <0.001 
BADL 19.8 ± 0.9 19.9 ± 0.4 19.9 ± 0.3 <0.001 
     
Figures in tables are mean ± SD or n (%) 
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 Table 7 Association between total tea intake score and physical functional performances (linear regression) (N=2398) 
 POMA Balance  POMA Gait  BADL  IADL 
 B±SE Beta P  B±SE Beta P  B±SE Beta P  B±SE Beta P 
Model 1 0.20±0.03 0.14 <0.001  0.02±0.004 0.08 <0.001  0.02±0.006 0.08 <0.001  0.08±0.01 0.12 <0.001 
                
Model 2 0.09±0.02 0.07 <0.001  0.01±0.004 0.07 0.001  0.02±0.006 0.07 0.002  0.06±0.01 0.08 <0.001 
                
Model 3 0.05±0.02 0.04 0.014  0.009±0.004 0.05 0.035  0.01±0.005 0.04 0.04  0.03±0.01 0.05 0.008 
                
 
Model 1: Unadjusted 
Model 2: Adjusted for age, gender, education , housing type 
Model 3: Adjusted for variables in Model 2 plus alcohol drinking, hospitalized in past year, hypertension, heart disease, diabetes mellitus, 
history of arthritis and hip fracture, BMI, creatinine, MMSE score, GDS score, haemoglobin and albumin , physical activities 
score 
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Table 8 The association between Black/oolong tea consumption, green tea consumption, coffee consumption and physical 
functional performance 
  
  Black/oolong tea consumer 
(N=934) 
 Green tea consumer 
(N=556) 
 Coffee consumer 
(N=1573) 
  B±SE Beta P  B±SE Beta P  B±SE Beta P 
           
POMA 
Balance  
Unadjusted 0.89±0.13 0.14 <0.001  0.87±0.15 0.12 <0.001  -0.16±0.15 -0.02 0.3 
 Adjusted * 0.29±0.11 0.05 0.01  0.3±0.14 0.04 0.03  -0.17±0.13 -0.02 0.2 
             
POMA 
Gait  
Unadjusted 0.1±0.02 0.09 <0.001  0.08±0.02 0.07 0.001  0.02±0.03 0.01 0.5 
 Adjusted * 0.05±0.02 0.05 0.04  0.06±0.03 0.05 0.03  0.01±0.02 0.01 0.6 
             
BADL  Unadjusted 0.12±0.03 0.09 <0.001  0.08±0.03 0.05 0.02  0.03±0.03 0.02 0.3 
 Adjusted * 0.06±0.03 0.05 0.04  0.06±0.04 0.04 0.1  0.03±0.03 0.02 0.3 
             
IADL  Unadjusted 0.42±0.07 0.12 <0.001  0.4±0.08 0.09 <0.001  -0.05±0.09 -0.01 0.6 
 Adjusted * 0.13±0.07 0.04 0.05  0.15±0.08 0.04 0.05  -0.02±0.07 -0.007 0.7 
           
 
Black/oolong tea consumption (any versus none) and green tea consumption (any versus none) were entered as independent 
variables in the model. 
Black/oolong tea consumption, green tea consumption, and coffee consumption were treated as dichotomous variables in the 
analysis (consumer vs. non-consumer) 
*Adjusted for age, gender, education and housing type, alcohol drinking, hospitalized in past year, hypertension, heart disease, 
diabetes mellitus, history of arthritis and hip fracture, BMI, MMSE score, GDS score, haemoglobin, albumin, creatinine, physical 
activities score, social and productive activities score, and coffee consumption (for tea), tea consumption (for coffee), ), green tea 
consumption (for black/oolong), black/oolong (for green tea) 
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 POMA Balance  POMA Gait  BADL  IADL 
 B±SE Beta P  B±SE Beta P  B±SE Beta P  B±SE Beta P 
Unadjusted   
              Non- consumer  Reference 
              Low consumer  0.67±0.15 0.10 <0.01  0.09±0.03 0.08 <0.01  0.11±0.04 0.08 <0.01  0.33±0.09 0.09 <0.01 
High consumer  1.26±0.43 0.07 <0.01  0.12±0.07 0.04 0.11  0.09±0.09 0.02 0.37  0.44±0.25 0.04 0.07 
  P trend  <0.01  P trend  <0.01  P trend  <0.01  P trend  <0.01 
Adjusted*                 
Non- consumer  Reference               
Low consumer  0.24±0.13 0.04 0.07  0.04±0.03 0.04 0.10  0.06±0.03 0.05 0.06  0.11±0.07 0.03 0.13 
High consumer  0.78±0.35 0.05 0.03  0.07±0.07 0.02 0.32  0.03±0.09 0.007 0.78  0.26±0.19 0.03 0.19 
 
 
 P trend  0.01  P trend  0.07  P trend  0.11  P trend  0.07 
Low consumer; tea score 1-3, High consumer ;tea score 4 and above 
Coding: 0=Never or rarely; 1=Less than 1cup/wk; 2=More than 1 cup/wk but less than 1 cup/day; 3=1-2 cups/day; 4= 3–5 cups/d; 5= 6–9 cups/d, 
and 6= 10 cups/d. 
*Adjusted for age, gender, education and housing type, alcohol drinking, hospitalized in past year, hypertension, heart disease, diabetes 
mellitus, history of arthritis and hip fracture, BMI, MMSE score, GDS score, haemoglobin, albumin, creatinine, physical activities 
score, green tea consumption 
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Table 10 The association between Green tea and physical function 
 
Green tea 
 POMA Balance  POMA Gait  BADL  IADL 
 B±SE Beta P  B±SE Beta P  B±SE Beta P  B±SE Beta P 
Unadjusted                 
Non- consumer  Reference               
Low consumer  0.86±0.15 0.12 <0.01  0.07±0.03 0.06 <0.01  0.08±0.03 0.05 0.02  0.41±0.08 0.09 <0.01 
High consumer  1.06±0.74 0.03 <0.15  0.09±0.12 0.02 0.45  0.01±0.17 0.001 0.9  0.33±0.42 0.02 0.43 
  P trend  <0.01  P trend  <0.01  P trend  0.03  P trend  <0.01 
Adjusted*                 
Non- consumer  Reference               
Low consumer  0.16±0.16 0.02 0.31  0.05±0.03 0.04 0.12  0.05±0.04 0.03 0.18  0.10±0.09 0.02 0.25 
High consumer  0.72±0.23 0.06 0.002  0.09±0.05 0.05 0.03  0.08±0.06 0.03 0.19  0.29±0.13 0.04 0.03 
  P trend  0.02  P trend  0.03  P trend  0.12  P trend  0.04 
Low consumer; tea score 1-3, High consumer ;tea score 4 and above 
Coding : 0=Never or rarely; 1=Less than 1cup/wk; 2=More than 1 cup/wk but less than 1 cup/day; 3=1-2 cups/day; 4= 3–5 cups/d; 5= 6–9 
cups/d, and 6= 10 cups/d. 
*Adjusted for age, gender, education and housing type, alcohol drinking, hospitalized in past year, hypertension, heart disease, 
diabetes mellitus, history of arthritis and hip fracture, BMI, MMSE score, GDS score, haemoglobin, albumin, creatinine, physical 
activities score, black/oolong tea consumption 
 
 




Figure 2  Associations of levels of tea consumption with marginal mean values of physical performance score 




We observed that increasing levels of tea consumption for all types of tea was 
positively associated with better physical performance in balance and gait, and 
instrumental and basic daily living activities. The observed associations 
remained statistically significant after adjusting for a large number of variables 
including socio-demographics, co-morbidities, cognitive function, depressive 
symptoms, physical and social activities and dietary factors, which are likely 
correlates of tea consumption and associated with physical function. Our 
results suggest that the observed associations of tea consumption with physical 
function measures are free of the confounding effects of other lifestyle, dietary 
and behavioral factors. 
 
Chronic degenerative diseases and long-term functional impairment, 
functional decline and disability accompany rapid ageing. Although almost all 
the organs of the body show a decline in activity with ageing; eating habits and 
digestion and absorption of food seem to show little decline in the generally 
healthy older adults. Disease and nutritional deficiency may occur together, 
especially when the maintenance of an adequate diet is limited by chronic 
degenerative diseases [74]. 
 
In our study, we found that 9 out of 10 seniors reported having at least one 
chronic health condition. 43% have at least three multiple conditions. The 
conditions were: hypertension (56%), blood lipid abnormalities (59%), major 
eye disorders (33%), arthritis and other musculoskeletal disorders (17%), 
diabetes (19%), coronary heart disease (6%), stroke (4%), significant 
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depressive symptoms (13%), psychiatric disorder diagnosis (11%), cognitive 
impairment (24%), dementia (65+ years) (6%). In addition, 3.5% reported a 
history of treatment for mental illness, 2% reported at least two falls in the past 
six months, and 4.1% was hospitalized at least once in the year. 
 
Our results are in agreement with the findings of a previous Japanese study 
[153] that showed a similar positive association between tea consumption and 
physical functional ability. There are however, some differences in the 
methodology and discrepancies in the results. The Japanese prospective cohort 
study examined the risk of incident functional disability that qualified for 
insurance certification for long-term care. Because not all candidates applied 
for insurance certification, the study might not have been completely free from 
detection bias. In the present study, physical functional ability was assessed 
directly using performance-based measures of gait and balance. Taken 
together, the two studies which used different study designs and outcome 
measures strengthen the evidence for the link between tea consumption and 
physical function. Also, both studies were consistent in showing a lack of 
parallel associations between coffee consumption and physical function.  
 
However, the two studies showed discrepant findings with respect to the type 
of tea consumed that was associated with physical function. While the 
Japanese study strongly suggested a positive association for green tea, and 
failed to show any association for black tea or oolong tea, our study showed a 
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positive association for both black/oolong tea and green tea (except BADL). 
An apparent explanation is that the vast majority of Japanese study participants 
drank green tea, whereas the vast majority of Chinese respondents in the 
present study drank both black and/or oolong tea and green tea. 
 
An apparent explanation is that the vast majority of Japanese study participants 
drank green tea, whereas our study sample had large numbers of both 
black/oolong tea consumers and green tea consumers. Our analysis results 
based on a study population with diverse tea drinking habit suggest that both 
green tea and black/oolong tea consumption are associated with better physical 
function. Since both black/oolong tea and green tea were entered the same 
regression models, the result support that the observed protective effects were 
independent of each other. Also, in the separate analysis for each of 
black/oolong tea and green tea the regression coefficients for high consumer 
were consistently larger than that for low consumers, and the linear trend was 
statically significantly for several outcome measures. A dose dependent 
association was supported. 
 
 With black/oolong tea, catechins in fresh green tea leaves undergo enzymatic 
oxidation during fermentation to form theaflavins and thearubigins. The 
amount of catechins is generally lower compared with green tea [133, 134]; 
however, the fermentation process does not alter significantly the free radical-
90 
 
scavenging activity [134], and catechins in green tea and theaflavins in 
black/oolong tea possesses equally strong antioxidative properties [183].  
 
Biologically, the association between tea consumption and physical function is 
attributable to the anti-inflammatory property of tea polyphenols in 
diminishing chronic inflammation underlying physical functional decline [150, 
151]. The same property of tea also contributes to its neuroprotective effects 
[147, 148] and the prevention of functional limitation and disability. Animal 
studies have also shown that tea has positive effects on collagen-induced 
arthritis [149]. In the elderly, oxidative protein damage is implicated in the 
pathogenesis of sarcopenia, resulting in lower muscle strength, and thus plays 
a major role in functional decline [126, 128]. The antioxidant properties of 
catechins, theaflavins, and thearubigins may thus improve physical 
performance and muscle strength [131]. There are possibly other underlying 
mechanisms as the effect of tea is likely due to the synergistic effect of 
multiple chemical components. 
 
The strengths of this study included the large size of the population-based 
sample and the use of both performance-based and self-reported measures of 
physical functional limitations and ADL disability. We controlled for a wide 
range of potential confounders in multivariate analyses which yielded 




There are limitations in this study. The present study did not include additional 
measures of bone mineral density, osteoporosis risk or distal mobility 
outcomes such as falls, which might be useful in supporting the observed 
relationships. The cross-sectional design of our study also limits drawing 
definite causal inferences of the observed relationships. The duration of tea 
consumption could be different among respondents that reported the same 
level of current tea intake, and we would expect the respondents with longer 
tea consumption duration would perform better on performance assessment 
and functional activities than those who have shorter duration. Because of this 
limitation, we were not able to examine the potential dose dependent 
relationship between lifelong tea intake (frequency × duration) and physical 
function. The study lacks biological markers of tea consumption such as with 
blood concentrations of theanine or other tea compounds, hence it was not 
possible to attribute the observed effects to any component in tea. We did not 
collect data on caloric intake, intake of meat, protein and carbohydrate, hence 
it was not possible to exclude the effect of unexplored food item. Although 
potential confounding variables are adjusted in the analysis, residual 
confounding remains a potential limitation.  
 
In conclusion, regular consumption of tea, particularly black or oolong tea, 
was associated with better physical and functional performance. This should 
be further investigated in longitudinal and interventional studies to determine 
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CHAPTER 7. SUMMARY AND CONCLUSION 
In a series of studies (Study I to Study III), using data collected from 
Singapore Longitudinal Ageing Study, we investigated the relationship 
between nutritional factors (albumin, hemoglobin, homocysteine, folate, and 
vitamin B-12), tea consumption, with and physical functional status and 
performance in older adults aged 55 and above. 
 
In Study I, we examined the independent association between serum albumin, 
haemoglobin and physical function and performances. In Study II, we 
examined the relationships between folate, vitamin B12, homocysteine and 
physical function and performances . In Study III, we examined the 
relationships between tea consumption and physical function and 
performances. 
 
In Study I, in cross-sectional multivariate analyses that adjusted for 
haemoglobin and other confounders, albumin showed a significant linear 
association (p<0.001) with POMA balance score (B=0.06, SE=0.02) and knee 
extension strength (B=0.70, SE=0.10). Independently of albumin, hemoglobin 
also showed a significant linear association with POMA balance score 
(B=0.09, SE=0.04). In longitudinal analyses, albumin was significantly 
associated with IADL decline (IADL total score drop>=1 during follow-up), 
OR= 0.92 (0.87 - 0.97), p=<0.01. The findings suggest that low levels of 
albumin and hemoglobin are potentially useful risk markers of physical 
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functional decline in older adults. The combination of malnutrition and 
systemic inflammation in older persons has been termed ‘malnutrition–
inflammation complex syndrome’ (MICS) and is obvious in cachexic patients 
with chronic heart failure, renal failure, diabetes, COPD, cancers, severe 
infections, injury and geriatric conditions. Because both protein energy 
malnutrition (PEM) and inflammation are strongly associated with each other 
and can change many nutritional measures in the same direction, and because 
the relative contributions of measures of these 2 conditions to each other and 
to outcomes in dialysis patients are not yet well defined, the terms MICS or 
malnutrition-inflammation atherosclerosis have been suggested to denote the 
important contribution of both of these conditions to dialysis outcome low 
albumin, anemia are the most commonly observed in these conditions. 
According to our findings, we suggested that nutritional bio markers, serum 
albumin and haemoglobin should be used to screen in the primary health care 
center. Hence, we can identify the modifiable risk factors for disabilities. 
Consequently, we can protect the elderly from unable to perform physical 
functions and impairment of daily activities [186]. 
 
In Study II, in multivariate analyses that controlled for gender, age, education, 
housing type, co-morbidities, hospitalization, GDS depression score, MMSE 
cognitive score, body mass index, creatinine, arthritis and hip fracture, serum 
albumin and haemoglobin, we found that homocysteine, independently of 
folate and vitamin B12, showed significant negative associations with POMA 
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balance (p=0.02), POMA gait scores (p<0.01) and IADL (p<0.01). Serum 
folate, independently of homocysteine, showed significant positive association 
only with POMA balance scores (p<0.01). No significant independent 
associations for B12 were observed. The independent effect of elevated 
homocystiene and low folate, but not B12, on physical and functional decline 
was supported in this study.  
 
After analyzing the data, I have stratified the data by presence of chronic diseases 
suggests that chronic diseases such as hypertension, diabetes mellitus, heart diseases, 
liver diseases, and kidney diseases may be the residual confounding factors. After 
including the interaction term, physical functional performances and activities of daily 
living (is/are) still associated with independent variables (Albumin, Haemoglobibin, 
Folate, Vitamin B12, Homocysteine, and Tea Consumption). Regression coefficients 
for main effects in models that include interaction terms are difficult to interpret. 
Hence, I have reported the P value for interaction in Results Chapter. However, the 
main findings remain in the subgroup of participants without chronic diseases in 
whom there is less potential of residual confounding by disease severity or treatment. 
In conclusion, the association between physical functional performances and 
nutritional biomarkers, homocysteine , and tea comsumption is still significant after 
adjusting co-morbidities. After adjusting the chronic diseases seperately in the 
hierrchial model, the association is still statistically significant. After stratification by 
chronic diseases, the association is attenuated in the disease group. These findings 
suggested that the chronic diseases may be potential confounders and a few diseases 
may be effect modifiers. 
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One limitation is because of a cross-sectional design, we cannot see the causal 
effect of vitamin B12 on physical functional performances. In another hospital 
based cohort study [187], they explained the null findings with B12, as well. 
Methylmalonic acid is highly sensitive and specific at determining poor B12 
status, whereas serum B12 is not very sensitive or specific, and the inadequacy 
of determining poor B12 status may possibly in our study, whereas 
methylmalonic acid testing was not done. In our study participants, vitamin 
B12 range is from 35 to 1476 pmol/L, but there may be technical problems 
with the assay and another possibility is because of the association between 
Haemoglobin and vitamin B12, e.g megaloblastic anaemia. 
 
In Study III, in multivariate analyses controlling for age, gender, education, 
housing type, co-morbidities, hospitalization, arthritis and hip fracture, GDS 
depression score, MMSE cognitive score, body mass index, creatinine, serum 
albumin, haemoglobin, physical activities score and coffee consumption, 
Study III showed that black/oolong tea high consumption was positively 
associated with better POMA balance score (B=0.78, SE=0.35 p trend 0.01), 
marginally associated with POMA gait score (B=0.07, SE=0.07 p trend =0.07) 
and IADL (B=0.26, SE=0.19 p trend=0.07). Green tea high consumption was 
positively associated with POMA balance (B=0.72, SE=0.23 p trend 0.02), 
POMA gait score (B=0.09, SE=0.05 p trend =0.03) and IADL (B=0.29, 
SE=0.13 p=0.04). Tea consumption was associated with better physical 
functional performances in community-living older adults. 
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All these results support the role of nutritional biomarkers and tea 
consumption in physical performance among elderly. Albumin and 
hemoglobin may be used as a nutritional marker for screening and prevention 
of physical functional decline and disability in primary care. Lowering plasma 
homocysteine could be effective measure for the prevention of physical 
functional decline. Despite that, these should be established by conducting 
randomized control trials. 
 
There are advantages of using nutritional biomarkers. Firstly, they provide 
accurate measures that can be correlated to dietary intake and can have less 
error than measured dietary intake [184]. Secondly these are objective 
measures that are independent of memory, capacity to describe foods [184]. 
Thirdly, errors associated with biomarker variables are independent of those 
associated with questionnaire data [184, 185]. 
 
It should be pointed out that there were limitations of these studies. 
Measurements at baseline only covered limited part of nutrition and therefore 
do not provide a complete picture of the relationship between nutrition and 
physical function and performances. Physical performance tests were not 
repeated at follow up, hence we were unable to demonstrate longitudinal 
relationship for nutritional factor with physical performances. The 
measurement errors that can affect the used measures of physical function are 
differences in item interpretation and problems in translation, differences in 
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the cognitive processes used in responding, differences in the appropriateness 
of response scales, and the appropriateness of data collection procedures. 
Performance might be changes under different conditions such as their current 
health conditions, medications. 
 
One of possible limitations in performance oriented mobility assessment test is 
due to some constraints in instructions. These are more cognitively demanding 
because it needs the participants to be able to follow commands, which makes 
difficulty in assessing cognitively impaired participants. Inflammation markers 
(Interleukin 1, Interleukin 6, tumour necrosis factor alpha, C-reactive protein, 
etc) were not measure in the present study and we are unable to further 
examine the complex relationships between nutrition, inflammation, and 
physical function.  
 
Thus, future studies investigating the effect of nutritional factor on physical 
function could broadly collect a wide range of nutritional data from the same 
group of elderly, including calorie, protein intake, other anthropometric 
measurements, inflammatory markers, micronutrients and macronutrients 
measurement and follow-up physical performance assessment should provide 




To confirm the physical functional effect of nutritional intervention and 
nutritional supplement, randomized control trials targeting at risk population 
(eg. those with high homocysteine level) could be conducted.  
Haemoglobin, Albumin, Folate, Vitamin B-12, Homocysteine, and tea 
consumption may have direct and buffering protective effects on physical 
functional performances. 
 
Nutritional biomarkers may have modifier effect on physical functional 
performances. Hence, basic screening tests, for instance, Serum albumin test, 
should be done in Primary care clinics. Our findings suggested that in order to 
conduct good clinical practice, we first close the gap of the quality of life 
between the elderly who lives in urban and in rural areas. 
 
Homocysteine is associated with cognitive function and physical functional 
performances. The associations of Homocysteine and chronic diseases such as 
Hypertension, Chronic Kidney Diseases, etc. were described in the previous 
studies. Our findings suggested that renal function impairments may be the 
possible physiological and biochemical mechanism of the link between 
nutritional status and physical functional performances. Folate may be one of 
the Vitamins which support the better cognitive function and physical 
functional performances. Although other countries, for instance, in U.S.A. 
enriched cereal grain products were fortified with folic acid from 1998 
onwards, in Singapore, there is no Island wide fortification practices enriched 
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cereal grain products. According to Agri-Food & Veterinary Authority of 
Singapore (AVA) replies, a number of manufacturing companies has informed 
that the Folate fortification of their products. 
 
Tea consumption is a habitual factor of the people in the world, it is also 
associated with social factor and leisure time activities.The elder person who 
lives alone can communicate with each other. In Singapre, consumers of hot 
and cold beverages may have better cognitive and physical functional 
performances. Therefore, we have suggested that tea consumption may be the 
protective factor for physical functional decline in the community living 
elderly. 
 
As the size of elderly population increases in Singapore, prevention of 
physical functional limitation and disability will become a crucial issue. The 
finding of the study could add value into our growing knowledge of nutrition 
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